WEBVTT

00:00:00.000 --> 00:00:03.540
Welcome to the deep dive. When you think about

00:00:03.540 --> 00:00:07.740
osteoarthritis, well, for most of us, it probably

00:00:07.740 --> 00:00:11.199
brings to mind older people, aching knees perhaps,

00:00:11.900 --> 00:00:15.000
maybe just that unavoidable bit of wear and tear

00:00:15.000 --> 00:00:16.780
that comes with a long life. That's the common

00:00:16.780 --> 00:00:18.500
perception, yes. But the research we're digging

00:00:18.500 --> 00:00:20.820
into today paints a really quite different picture.

00:00:21.399 --> 00:00:24.039
It's frankly quite an urgent story. It is indeed.

00:00:24.140 --> 00:00:27.879
It shows osteoarthritis not just as an older

00:00:27.879 --> 00:00:29.859
person's disease, but something that's actually

00:00:29.859 --> 00:00:33.759
having a significant impact on younger, active

00:00:33.759 --> 00:00:36.020
people. Often triggered by injuries. That's a

00:00:36.020 --> 00:00:38.159
key point. And it comes with a pretty hefty price

00:00:38.159 --> 00:00:41.359
tag, too, doesn't it? Personally, but also economically.

00:00:41.640 --> 00:00:43.979
Absolutely. The costs are substantial. So we've

00:00:43.979 --> 00:00:46.759
gathered research papers looking at, well, everything,

00:00:47.020 --> 00:00:50.799
really, from those subtle early signs. The microscopic

00:00:50.799 --> 00:00:53.100
change is happening inside the joint. right through

00:00:53.100 --> 00:00:55.280
to the sheer numbers who's affected the financial

00:00:55.280 --> 00:00:58.340
fallout. The underlying biology, which is fascinating.

00:00:58.500 --> 00:01:00.500
And of course, what we're actually doing now

00:01:00.500 --> 00:01:02.700
and maybe hoping to do in the future to treat

00:01:02.700 --> 00:01:05.959
it. So our mission in this deep dive is simple,

00:01:06.000 --> 00:01:09.000
really. We want cut through all that complexity,

00:01:09.379 --> 00:01:11.620
pull out the most important insights from these,

00:01:11.840 --> 00:01:13.879
let's face it, quite technical sources. Take

00:01:13.879 --> 00:01:16.219
advance, yes. And give you the clear, actionable

00:01:16.219 --> 00:01:19.280
knowledge you need to get up to speed quickly

00:01:19.280 --> 00:01:23.409
on early OA. You know, what it is, why it's hitting

00:01:23.409 --> 00:01:26.370
younger people, what it really costs, and where

00:01:26.370 --> 00:01:28.609
the science is heading. That's right. And it's

00:01:28.609 --> 00:01:30.430
absolutely crucial, as you said, to understand

00:01:30.430 --> 00:01:33.049
that we're distinguishing early osteoarthritis,

00:01:33.510 --> 00:01:36.569
early OA, as a specific thing. Right. It's not

00:01:36.569 --> 00:01:38.790
just the start of the end -stage disease. Precisely.

00:01:38.810 --> 00:01:41.269
It's not just the very first twinge of late -stage

00:01:41.269 --> 00:01:43.829
disease. Right. Being able to accurately define

00:01:43.829 --> 00:01:46.689
this early phase, both clinically by what we

00:01:46.689 --> 00:01:49.250
see and structurally what's happening at a tissue

00:01:49.250 --> 00:01:52.109
level, That's the real key. Why is that definition

00:01:52.109 --> 00:01:54.849
so important? Because it's how we identify those

00:01:54.849 --> 00:01:57.670
people at highest risk early on. And that's when

00:01:57.670 --> 00:02:00.709
intervention treatment has the greatest potential

00:02:00.709 --> 00:02:02.670
to actually make a difference. The sources we

00:02:02.670 --> 00:02:05.609
looked at highlight that there's been quite significant

00:02:05.609 --> 00:02:07.989
progress recently in refining this definition,

00:02:08.509 --> 00:02:10.550
moving beyond just looking for changes you might

00:02:10.550 --> 00:02:12.770
see on a standard x -ray. Right, looking deeper.

00:02:13.439 --> 00:02:16.139
Let's unpack this insidious phase the papers

00:02:16.139 --> 00:02:18.759
describe. What does that actually mean for someone

00:02:18.759 --> 00:02:21.699
who might be developing early OA? Insidious.

00:02:22.680 --> 00:02:25.500
Well, it basically means it's often subtle. It

00:02:25.500 --> 00:02:27.919
can almost sneak up on you. Not dramatic. Not

00:02:27.919 --> 00:02:30.479
usually, no. Compared to someone with advanced

00:02:30.479 --> 00:02:33.800
OA, who might have constant, quite severe pain,

00:02:34.379 --> 00:02:36.919
patients in this early phase can be largely asymptomatic.

00:02:37.060 --> 00:02:39.379
So feeling nothing at all? Potentially, yes.

00:02:39.639 --> 00:02:42.849
Or they might have symptoms, but they're reduced,

00:02:43.370 --> 00:02:45.909
maybe lower intensity pain, perhaps a bit of

00:02:45.909 --> 00:02:48.169
stiffness, but not necessarily there all the

00:02:48.169 --> 00:02:50.050
time. And the type of pain is different too,

00:02:50.110 --> 00:02:51.629
isn't it? I found the description in the sources

00:02:51.629 --> 00:02:54.930
quite interesting. Yes, it is distinct. In early

00:02:54.930 --> 00:02:57.250
OA, the pain is typically mechanical, so it's

00:02:57.250 --> 00:02:59.530
related to activity. Right. It's often described

00:02:59.530 --> 00:03:02.270
as a sort of deep ache, maybe not always easy

00:03:02.270 --> 00:03:04.370
to pinpoint exactly where it's coming from. Any

00:03:04.370 --> 00:03:07.409
specific activities mentioned? Yes. The sources

00:03:07.409 --> 00:03:09.949
specifically point to weight -bearing activities

00:03:09.949 --> 00:03:12.689
that involve loading and bending the joint. Things

00:03:12.689 --> 00:03:15.550
like using stairs. That's often one of the first

00:03:15.550 --> 00:03:18.550
things people might notice pain with. OK, stairs.

00:03:18.789 --> 00:03:21.550
That's quite specific. And it's a stark contrast

00:03:21.550 --> 00:03:24.370
to advanced OA, where the pain can become constant.

00:03:24.490 --> 00:03:27.469
It might wake people up at night. It's significantly

00:03:27.469 --> 00:03:30.419
worse. with activity, though it might ease off

00:03:30.419 --> 00:03:32.939
a bit with rest. So very different profiles.

00:03:33.159 --> 00:03:34.800
Very different. And there's even uncertainty

00:03:34.800 --> 00:03:37.060
acknowledged in the sources about whether someone

00:03:37.060 --> 00:03:40.080
who feels completely pain -free might actually

00:03:40.080 --> 00:03:42.379
already have underlying early OA changes happening

00:03:42.379 --> 00:03:44.979
silently. That pain -free but changes happening

00:03:44.979 --> 00:03:47.460
idea that really sticks with you, doesn't it?

00:03:47.539 --> 00:03:50.319
It highlights just how subtle this can be. It

00:03:50.319 --> 00:03:52.979
does. So if the clinical signs are minimal, what

00:03:52.979 --> 00:03:55.120
about the physical changes inside the joint?

00:03:55.240 --> 00:03:57.659
Where do they actually start? Well, according

00:03:57.659 --> 00:04:00.360
to these papers, the primary sites of change

00:04:00.360 --> 00:04:03.780
in early OA are the articular cartilage. That's

00:04:03.780 --> 00:04:06.120
the smooth lining on the bone ends. That's the

00:04:06.120 --> 00:04:09.560
one, yes. That smooth surface. And the subconjural

00:04:09.560 --> 00:04:11.680
bone, which is the bone directly underneath the

00:04:11.680 --> 00:04:13.840
cartilage. OK, cartilage and the bone beneath.

00:04:14.199 --> 00:04:15.879
But, and this is important, it's not just those

00:04:15.879 --> 00:04:19.480
two. The sources are very clear. Early OA is

00:04:19.610 --> 00:04:22.329
a whole joint disease. Not just wear and tear

00:04:22.329 --> 00:04:24.610
on one surface, though. Absolutely not. It affects

00:04:24.610 --> 00:04:26.649
all the structures in the joint, the synovial

00:04:26.649 --> 00:04:29.290
membrane, that's the lining, the interpatellar

00:04:29.290 --> 00:04:33.250
fat pad, the menisci, shock absorbers, the joint

00:04:33.250 --> 00:04:35.990
capsule, the ligaments, even the surrounding

00:04:35.990 --> 00:04:38.670
muscles. Changes are happening across the board

00:04:38.670 --> 00:04:41.689
right from the early stages. Wow. OK. So it's

00:04:41.689 --> 00:04:44.389
systemic within the joint. Is there a way researchers

00:04:44.389 --> 00:04:47.350
actually grade these early changes, particularly

00:04:47.350 --> 00:04:52.319
in the cartilage? Yes, there is. The RRSI histopathological

00:04:52.319 --> 00:04:55.319
grading system is key here. It looks at microscopic

00:04:55.319 --> 00:04:58.519
changes in the cartilage tissue itself. Microscopic

00:04:58.519 --> 00:05:00.959
level. Exactly. And the grade is particularly

00:05:00.959 --> 00:05:03.600
relevant for early OA because it reflects the

00:05:03.600 --> 00:05:05.620
depth of the damage. It starts at the surface

00:05:05.620 --> 00:05:08.139
and progresses inwards. So how deep the problem

00:05:08.139 --> 00:05:11.920
goes? Precisely. You might see early disruption

00:05:11.920 --> 00:05:14.910
just on the surface. Maybe tiny cracks. or what

00:05:14.910 --> 00:05:17.050
they call fibrillations. Fibrillations. Like

00:05:17.050 --> 00:05:20.290
tiny fraying. And eventually, you might see vertical

00:05:20.290 --> 00:05:22.689
fissures starting to extend down into the middle

00:05:22.689 --> 00:05:25.970
zone of the cartilage layer. OK. This grating

00:05:25.970 --> 00:05:28.509
focuses on the area with the most advanced damage,

00:05:29.089 --> 00:05:31.069
even if that area is quite small to begin with.

00:05:31.310 --> 00:05:34.430
And you mentioned stage as well. How is that

00:05:34.430 --> 00:05:36.509
different? The stage is about the horizontal

00:05:36.509 --> 00:05:39.100
spread. So how much of the joint surface area

00:05:39.100 --> 00:05:42.579
is affected, grade is depth, stages spread across

00:05:42.579 --> 00:05:44.720
the compartment, and they're considered independent

00:05:44.720 --> 00:05:47.000
of each other. Got it. Clayed for depth, staged

00:05:47.000 --> 00:05:48.379
for spread. And you said the bone underneath

00:05:48.379 --> 00:05:50.500
is changing early too. Correct. The subchondral

00:05:50.500 --> 00:05:53.500
bone shows changes right from the start. There's

00:05:53.500 --> 00:05:56.019
a progressive thickening of the subchondral plate

00:05:56.019 --> 00:05:59.000
that's the very dense layer right under the cartilage,

00:05:59.779 --> 00:06:02.500
and also structural alterations happening, the

00:06:02.500 --> 00:06:05.360
spongiosa, the more porous spongy bone just below

00:06:05.360 --> 00:06:07.500
that. So changes happening at the same time,

00:06:07.740 --> 00:06:11.079
cartilage and bone? Yes, simultaneously. In the

00:06:11.079 --> 00:06:13.759
cartilage layer and the bone supporting it, it's

00:06:13.759 --> 00:06:16.360
a coupled process. Given how subtle the symptoms

00:06:16.360 --> 00:06:18.920
can be and how early these changes start, I'm

00:06:18.920 --> 00:06:21.480
guessing standard imaging like a regular x -ray

00:06:21.480 --> 00:06:24.000
or even a normal MRI isn't brilliant at picking

00:06:24.000 --> 00:06:26.699
this up. That's precisely the challenge. The

00:06:26.699 --> 00:06:28.939
sources explain that conventional morphological

00:06:28.939 --> 00:06:31.540
MRI, which is what's typically used in clinics...

00:06:31.540 --> 00:06:34.500
The standard scan. Yes, the standard scan. It

00:06:34.500 --> 00:06:37.240
often misses these very early changes in the

00:06:37.240 --> 00:06:40.120
cartilage. Things like the initial loss of key

00:06:40.120 --> 00:06:43.139
molecules in the matrix. Like what? Like glycosomic

00:06:43.139 --> 00:06:46.449
glycans or... gags which hold water, and also

00:06:46.449 --> 00:06:48.649
the initial loosening of the collagen network.

00:06:49.329 --> 00:06:51.209
These things can happen when the cartilage still

00:06:51.209 --> 00:06:54.149
looks superficially, pretty normal, or maybe

00:06:54.149 --> 00:06:56.509
only minimally changed on a standard scan. So

00:06:56.509 --> 00:06:58.689
you need something more sophisticated. Absolutely.

00:06:59.050 --> 00:07:00.990
This is where the advanced MRI techniques come

00:07:00.990 --> 00:07:03.069
into play. Methods the source is referred to

00:07:03.069 --> 00:07:05.230
as pre -structural cartilage assessment. Pre

00:07:05.230 --> 00:07:07.930
-structural. So seeing changes before the structure

00:07:07.930 --> 00:07:10.829
visibly breaks down. Exactly. Techniques like

00:07:10.829 --> 00:07:14.160
T2 mapping and DGMR. T2 mapping, for instance,

00:07:14.319 --> 00:07:16.459
can detect subtle changes in the water content

00:07:16.459 --> 00:07:18.720
and the organization of the cartilage matrix

00:07:18.720 --> 00:07:21.959
that signal early degeneration, even before you

00:07:21.959 --> 00:07:24.300
see thinning or defects. That's clever. How does

00:07:24.300 --> 00:07:27.220
it work? Well, T2 values relate to water mobility

00:07:27.220 --> 00:07:29.660
and collagen structure. The sources reference

00:07:29.660 --> 00:07:32.319
data from the big osteoarthritis initiative study.

00:07:32.560 --> 00:07:36.160
The OAI? Yes, the OAI. It showed subtle but significant

00:07:36.160 --> 00:07:38.759
differences in T2 values between healthy knees

00:07:38.759 --> 00:07:42.069
and those with early signs of OA on x -ray. or

00:07:42.069 --> 00:07:45.129
even knees just considered at risk. This suggests

00:07:45.129 --> 00:07:47.110
the technique can pick up early differences that

00:07:47.110 --> 00:07:49.129
might be linked to risk factors. Fascinating.

00:07:49.209 --> 00:07:51.449
Almost like seeing a biochemical footprint the

00:07:51.449 --> 00:07:53.689
standard MRI can't. And what about DGE -ERiC?

00:07:53.810 --> 00:07:56.990
That uses a contrast agent, right? Yes. DGE -ERiC.

00:07:57.050 --> 00:07:59.670
That stands for delayed gadolinium enhanced MRI

00:07:59.670 --> 00:08:02.889
of cartilage. It uses a negatively charged contrast

00:08:02.889 --> 00:08:05.459
agent. Healthy cartilage has lots of negatively

00:08:05.459 --> 00:08:07.740
charged gags which repel the contrast agent.

00:08:08.379 --> 00:08:11.360
Where gags are depleted, in early away, more

00:08:11.360 --> 00:08:14.379
contrast agent can diffuse in. Ah, so less gags

00:08:14.379 --> 00:08:17.319
means more contrast signal. Exactly. By measuring

00:08:17.319 --> 00:08:19.680
how much contrast agent gets into the cartilage

00:08:19.680 --> 00:08:22.519
after a delay, you can indirectly measure the

00:08:22.519 --> 00:08:26.120
JAG concentration. Lower JAGs mean more contrast

00:08:26.120 --> 00:08:28.879
uptake, indicating early degeneration before

00:08:28.879 --> 00:08:30.959
you might see structural loss on a normal scan.

00:08:31.480 --> 00:08:33.480
These advanced techniques are really pushing

00:08:33.480 --> 00:08:35.519
the frontier of detecting the disease much, much

00:08:35.519 --> 00:08:37.879
earlier. It's amazing what they can see now.

00:08:38.039 --> 00:08:39.980
The sources also mention a whole host of different

00:08:39.980 --> 00:08:42.340
scoring systems that researchers use with MRI,

00:08:42.840 --> 00:08:45.120
alongside the older x -ray methods like Kellgren

00:08:45.120 --> 00:08:46.580
-Lawrence that people might be more familiar

00:08:46.580 --> 00:08:48.519
with. Yes, it's a bit of an alphabet soup, isn't

00:08:48.519 --> 00:08:53.080
it? You see Mayoax, Worms, Aqloas, Kimbriss mentioned

00:08:53.080 --> 00:08:55.700
for MRI. Right. And then the familiar Kellgren

00:08:55.700 --> 00:08:58.440
-Lawrence, IKDC, Allbeck scales for x -rays.

00:08:58.779 --> 00:09:01.440
The key point the sources make here is that there's

00:09:01.440 --> 00:09:04.120
actually quite a lot of variation in these different

00:09:04.120 --> 00:09:06.860
assessment tools, especially the semi -quantitative

00:09:06.860 --> 00:09:09.620
MRI ones. Oh, so? Well, they divide the joint

00:09:09.620 --> 00:09:11.559
up differently. They grade features in varying

00:09:11.559 --> 00:09:14.279
ways. This variability isn't just an academic

00:09:14.279 --> 00:09:16.700
detail. It can genuinely affect the outcomes

00:09:16.700 --> 00:09:19.240
reported in different studies. Ah, so it makes

00:09:19.240 --> 00:09:21.820
comparing research harder. Exactly. It makes

00:09:21.820 --> 00:09:23.980
comparing findings across different studies quite

00:09:23.980 --> 00:09:25.799
challenging, especially when you're trying to

00:09:25.799 --> 00:09:27.960
track subtle changes in early disease progression.

00:09:28.500 --> 00:09:30.720
Consistency is key, and we're still working towards

00:09:30.720 --> 00:09:34.879
that. OK, so early OA is subtle, involve specific

00:09:34.879 --> 00:09:37.440
tissue changes in the whole joint, and needs

00:09:37.440 --> 00:09:41.039
advanced tech to really see it early. Now let's

00:09:41.039 --> 00:09:43.679
really focus on who is getting it early. The

00:09:43.679 --> 00:09:46.559
sources make a very strong case for post -traumatic

00:09:46.559 --> 00:09:49.720
osteoarthritis PTOA. They really do. They highlight

00:09:49.720 --> 00:09:54.059
PTOA of the lower extremity, so hip, knee, ankle,

00:09:54.259 --> 00:09:57.399
as a major pathway. They often refer to it using

00:09:57.399 --> 00:10:00.039
phrases like the premature aging of youthful

00:10:00.039 --> 00:10:02.820
joints. Premature aging. That really shifts the

00:10:02.820 --> 00:10:04.639
narrative, doesn't it? It fundamentally changes

00:10:04.639 --> 00:10:06.580
it. It moves away from just thinking about age

00:10:06.580 --> 00:10:09.179
-related wear and tear to a narrative driven

00:10:09.179 --> 00:10:11.759
significantly by joint injury, often happening

00:10:11.759 --> 00:10:14.990
in younger... quite active populations. And the

00:10:14.990 --> 00:10:17.070
statistics provided, particularly around common

00:10:17.070 --> 00:10:20.070
injuries like ACL tears and meniscus tears, they're

00:10:20.070 --> 00:10:22.450
quite stark, actually. They really are. The data

00:10:22.450 --> 00:10:24.769
presented is compelling. If you rupture your

00:10:24.769 --> 00:10:27.570
anterior cruciate ligament, your ACL, or tear

00:10:27.570 --> 00:10:29.889
your meniscus, or maybe even both. Which often

00:10:29.889 --> 00:10:31.450
happens together. Which often happens together,

00:10:31.570 --> 00:10:35.070
yes. You face nearly a 50 % chance of crowing

00:10:35.070 --> 00:10:37.789
flip, basically, of developing symptomatic OA

00:10:37.789 --> 00:10:40.629
within 10 to 20 years of that initial injury.

00:10:41.309 --> 00:10:44.620
50%. Within 10, 20 years, that's huge. It's huge.

00:10:45.019 --> 00:10:47.220
And given that most people who tear their ACL

00:10:47.220 --> 00:10:49.500
are under the age of 30. Right, it's often younger

00:10:49.500 --> 00:10:52.960
athletes. Exactly. This means a significant number

00:10:52.960 --> 00:10:55.179
of people are being diagnosed with PTOA before

00:10:55.179 --> 00:10:58.200
they even turn 50. That's roughly five years

00:10:58.200 --> 00:11:01.059
earlier than the average age of OA onset in the

00:11:01.059 --> 00:11:03.659
general population, which is around 55. So it's

00:11:03.659 --> 00:11:06.720
bringing the onset forward considerably. Considerably.

00:11:06.919 --> 00:11:09.559
The sources mention athletes sometimes showing

00:11:09.559 --> 00:11:12.639
signs as early as their 30s. There's a key study

00:11:12.639 --> 00:11:15.000
by Lomander and colleagues often cited. They

00:11:15.000 --> 00:11:17.620
looked at female soccer players 12 years after

00:11:17.620 --> 00:11:20.919
an ACL reconstruction. They found radiographic

00:11:20.919 --> 00:11:23.740
OA, so visible changes on x -ray in the injured

00:11:23.740 --> 00:11:27.019
knee, in over half of them, 51%. Over half? Compare

00:11:27.019 --> 00:11:29.659
that to their other uninjured knee, only 8 %

00:11:29.659 --> 00:11:31.899
showed OA changes. That difference is massive.

00:11:32.039 --> 00:11:35.240
51 % versus 8%. That's a powerful illustration

00:11:35.240 --> 00:11:38.600
of how much that injury drives the process. Beyond

00:11:38.600 --> 00:11:40.940
that first injury, the sources also talk about

00:11:40.940 --> 00:11:44.139
how common recurrent ACL injury is and the risk

00:11:44.139 --> 00:11:46.519
factors linked to it. Yes, recurrence is a really

00:11:46.519 --> 00:11:48.539
significant concern and unfortunately it happens

00:11:48.539 --> 00:11:50.320
quite frequently. More common than people might

00:11:50.320 --> 00:11:52.980
think. I think so. The sources point to various

00:11:52.980 --> 00:11:56.200
risk factors, but sport type and the level of

00:11:56.200 --> 00:11:58.419
competition really stand out. Higher level, higher

00:11:58.419 --> 00:12:01.830
risk. Seems so. Data from the Moon Group, a large

00:12:01.830 --> 00:12:05.149
U .S. cohort, showed similar risks of re -injuring

00:12:05.149 --> 00:12:07.429
the surgically reconstructed knee and injuring

00:12:07.429 --> 00:12:10.250
the opposite knee within just two years. Another

00:12:10.250 --> 00:12:13.169
study cited looked at NCAA university athletes

00:12:13.169 --> 00:12:16.690
and high school athletes. It found an 8 .7 %

00:12:16.690 --> 00:12:20.110
recurrence rate overall. But the NCAA athletes

00:12:20.110 --> 00:12:23.690
faced a 4 .6 -time higher likelihood of a recurrent

00:12:23.690 --> 00:12:25.690
injury compared to the high schoolers. Four and

00:12:25.690 --> 00:12:28.230
a half times higher at the NCAA level, so the

00:12:28.230 --> 00:12:30.049
intensity and demands of those higher -level

00:12:30.049 --> 00:12:32.870
sports significantly increased the risk of reinjury.

00:12:32.990 --> 00:12:35.350
It appears so. Do they mention which sports had

00:12:35.350 --> 00:12:38.049
the highest rates? Yes. According to a 10 -year

00:12:38.049 --> 00:12:40.889
NCAA study cited, the highest recurrent rupture

00:12:40.889 --> 00:12:44.090
rates when measured per athletic exposure were

00:12:44.090 --> 00:12:46.929
in men's American football, women's gymnastics,

00:12:47.530 --> 00:12:49.909
women's soccer. Okay, interesting mix there.

00:12:50.230 --> 00:12:52.690
They also noted that non -contact recurrent tears,

00:12:53.110 --> 00:12:55.769
so not from a direct hit, were more common in

00:12:55.769 --> 00:12:58.309
the preseason or postseason periods, training

00:12:58.309 --> 00:13:00.409
phases perhaps. Right, maybe when conditioning

00:13:00.409 --> 00:13:02.870
isn't quite optimal. Could be. Interestingly,

00:13:03.029 --> 00:13:05.230
while men overall had a higher rate of recurrent

00:13:05.230 --> 00:13:07.929
rupture in that particular data set, the ratio

00:13:07.929 --> 00:13:10.450
of recurrent injuries compared to primary injuries

00:13:10.450 --> 00:13:13.309
actually decreased for both genders over the

00:13:13.309 --> 00:13:16.960
study period. Oh. What might that suggest? Well,

00:13:17.139 --> 00:13:19.000
it perhaps suggests some improvements over time

00:13:19.000 --> 00:13:21.600
in prevention strategies or maybe surgical techniques

00:13:21.600 --> 00:13:24.240
or rehabilitation. Yeah. Although the absolute

00:13:24.240 --> 00:13:26.980
risk clearly remains significant. So repeated

00:13:26.980 --> 00:13:29.460
injury or maybe just playing certain sports at

00:13:29.460 --> 00:13:31.799
a very high level keeps that OA risk elevated.

00:13:32.299 --> 00:13:34.159
What about meniscus injuries? The sources are

00:13:34.159 --> 00:13:36.080
very direct about that link. One quote says,

00:13:36.480 --> 00:13:38.419
the relationship between meniscal injury and

00:13:38.419 --> 00:13:41.480
OA is plain to see. With considerable literature

00:13:41.480 --> 00:13:44.299
reporting their strong association. Yes, that

00:13:44.299 --> 00:13:46.480
quote really highlights the consensus in the

00:13:46.480 --> 00:13:50.700
field. A meniscal injury immediately fundamentally

00:13:50.700 --> 00:13:54.259
alters the joint environment. How so? The sources

00:13:54.259 --> 00:13:56.980
explain that the OA cycle begins very early after

00:13:56.980 --> 00:13:59.960
injury, often at a cellular and biochemical level.

00:14:00.350 --> 00:14:02.710
even before the mechanical changes become really

00:14:02.710 --> 00:14:05.429
obvious. So change is happening unseen. Exactly.

00:14:05.590 --> 00:14:08.669
When the meniscus is damaged, it loses its ability

00:14:08.669 --> 00:14:10.669
to perform its vital functions, distributing

00:14:10.669 --> 00:14:13.409
load evenly across the joint, absorbing shock,

00:14:13.909 --> 00:14:16.490
providing stability. And this mechanical failure

00:14:16.490 --> 00:14:18.590
essentially accelerates the breakdown process

00:14:18.590 --> 00:14:21.389
that leads to OA. The greater the initial damage

00:14:21.389 --> 00:14:23.830
to the meniscus, the more impaired its biomechanical

00:14:23.830 --> 00:14:26.309
function becomes, and generally, the faster the

00:14:26.309 --> 00:14:29.200
OA progression. Are certain types of meniscus

00:14:29.200 --> 00:14:32.460
tears worse than others for triggering OA? Yes,

00:14:32.620 --> 00:14:34.500
the research points quite strongly in that direction.

00:14:34.840 --> 00:14:37.360
The sources specifically call out meniscal extrusions.

00:14:37.720 --> 00:14:40.139
Extrusions? What's that? That's where the meniscus

00:14:40.139 --> 00:14:42.220
sort of gets squeezed out from its normal position

00:14:42.220 --> 00:14:46.190
between the bones. That... and large radial tears

00:14:46.190 --> 00:14:48.470
that run across the width of the meniscus. Right.

00:14:48.750 --> 00:14:50.990
These seem to be the most significant contributors

00:14:50.990 --> 00:14:53.710
to the onset and progression of OA. More so than

00:14:53.710 --> 00:14:56.210
other tear types. They note that smaller tears,

00:14:56.429 --> 00:14:58.690
perhaps like longitudinal tears running along

00:14:58.690 --> 00:15:01.710
the length of the meniscus, might have less dramatic

00:15:01.710 --> 00:15:04.909
initial biochemical effects, which perhaps means

00:15:04.909 --> 00:15:08.029
their long -term OA risk might sometimes be underestimated.

00:15:08.210 --> 00:15:11.909
Okay. And what about surgery? Specifically, removing

00:15:11.909 --> 00:15:15.529
torn meniscal tissue A meniscectomy. How does

00:15:15.529 --> 00:15:18.370
that impact the joint long -term? Ah, well, the

00:15:18.370 --> 00:15:20.769
sources are pretty clear on this. Meniscectomy,

00:15:20.870 --> 00:15:23.990
especially removing a significant portion, significantly

00:15:23.990 --> 00:15:26.389
accelerates degenerative changes in the joint.

00:15:26.490 --> 00:15:28.690
Even if it helps symptoms initially? Yes, that's

00:15:28.690 --> 00:15:31.350
the paradox. Studies with long -term follow -up

00:15:31.350 --> 00:15:34.269
show clear radiological progression of OA after

00:15:34.269 --> 00:15:36.809
meniscectomy, even if patients report feeling

00:15:36.809 --> 00:15:38.909
much better clinically in the short term. Any

00:15:38.909 --> 00:15:41.509
specific studies mentioned? The Paradoski study

00:15:41.509 --> 00:15:44.320
is cited as a prime example. It followed patients

00:15:44.320 --> 00:15:48.259
for nearly 25 years after meniscectomy. 25 years.

00:15:48.519 --> 00:15:52.019
Yes, a long time. It showed a much higher incidence

00:15:52.019 --> 00:15:56.120
of OA both in the main tibiofemoral joint and

00:15:56.120 --> 00:15:58.779
behind the kneecap, the patellofemoral joint,

00:15:59.120 --> 00:16:01.440
as well as other structural changes in the operated

00:16:01.440 --> 00:16:04.799
knee compared to the unoperated knee. That's

00:16:04.799 --> 00:16:07.440
compelling long -term evidence. It is. And a

00:16:07.440 --> 00:16:10.539
more recent study also found significant OA progression

00:16:10.539 --> 00:16:13.460
after arthroscopic partial menesectomy, just

00:16:13.460 --> 00:16:16.639
removing the torn part, particularly noting higher

00:16:16.639 --> 00:16:19.259
risk in patients with a higher BMI and those

00:16:19.259 --> 00:16:22.379
with degenerative tears rather than acute traumatic

00:16:22.379 --> 00:16:24.759
tears. They point out this finding actually goes

00:16:24.759 --> 00:16:26.879
against some of the previous literature, which

00:16:26.879 --> 00:16:28.980
sometimes suggested degenerative tears were less

00:16:28.980 --> 00:16:31.139
problematic. So it seems even partial removal

00:16:31.139 --> 00:16:33.279
carries a significant long -term risk. It sounds

00:16:33.279 --> 00:16:35.620
like while menesectomy might fix immediate symptoms,

00:16:35.960 --> 00:16:37.690
your potential borrowing from the future health

00:16:37.690 --> 00:16:39.470
of the joint. That's a very good way to put it.

00:16:39.549 --> 00:16:41.250
It's the difficult trade -off that's highlighted.

00:16:42.110 --> 00:16:44.169
The sources strongly conclude that patients with

00:16:44.169 --> 00:16:47.210
any significant meniscal injury should be considered

00:16:47.210 --> 00:16:49.330
at high risk for developing OA down the line.

00:16:49.629 --> 00:16:52.009
So what's the implication for treatment then?

00:16:52.470 --> 00:16:54.409
It emphasizes the need for treatments that are

00:16:54.409 --> 00:16:57.529
really focused on restoring the meniscus' integrity

00:16:57.529 --> 00:17:00.769
and function whenever possible. So repair rather

00:17:00.769 --> 00:17:03.799
than removal if feasible. But they also know

00:17:03.799 --> 00:17:06.079
that even surgical treatments, whether it's a

00:17:06.079 --> 00:17:09.180
repair or a partial removal, still carry an increased

00:17:09.180 --> 00:17:12.339
OA risk compared to a completely healthy joint.

00:17:12.519 --> 00:17:15.539
So no easy answers. No easy answers. Deciding

00:17:15.539 --> 00:17:18.380
how to manage a tear requires very careful consideration

00:17:18.380 --> 00:17:20.700
of the individual patient, their activity level,

00:17:21.059 --> 00:17:23.279
their age, and the specific characteristics of

00:17:23.279 --> 00:17:25.539
their tear. Beyond the ACL and menistis, the

00:17:25.539 --> 00:17:27.940
sources briefly mention intraarticular fractures

00:17:27.940 --> 00:17:30.059
breaks that go right into the joint surface as

00:17:30.059 --> 00:17:33.500
another cause of PTOA. Yes, IAFs are acknowledged

00:17:33.500 --> 00:17:36.119
as contributing to the risk of developing PTOA.

00:17:36.660 --> 00:17:38.759
The sources state that while this link is known,

00:17:39.079 --> 00:17:41.920
we actually need more research to better quantify

00:17:41.920 --> 00:17:44.279
the risk associated with different fracture types

00:17:44.279 --> 00:17:46.559
and patterns. And to develop better treatments.

00:17:46.839 --> 00:17:48.819
Exactly. To develop and implement treatments

00:17:48.819 --> 00:17:51.599
that can truly mitigate that risk and prevent

00:17:51.599 --> 00:17:55.000
or delay PTOA in these often complex injury cases.

00:17:55.279 --> 00:17:58.440
Okay. So we've firmly established that injuries

00:17:58.440 --> 00:18:01.839
are a major driver of early OA, particularly

00:18:01.839 --> 00:18:05.359
in younger active people. Why is this becoming

00:18:05.359 --> 00:18:08.380
such a significant problem, especially from an

00:18:08.380 --> 00:18:10.759
economic perspective, hitting people who are

00:18:10.759 --> 00:18:13.099
often in their working prime? This is where the

00:18:13.099 --> 00:18:15.119
picture really broadens out beyond just personal

00:18:15.119 --> 00:18:17.599
health to become a major societal and economic

00:18:17.599 --> 00:18:20.420
challenge. Unlike many older OA patients who

00:18:20.420 --> 00:18:23.019
might already be retired, these younger individuals

00:18:23.019 --> 00:18:24.799
are typically right in the middle of their working

00:18:24.799 --> 00:18:27.000
lives, often with decades of career ahead of

00:18:27.000 --> 00:18:29.319
them. So the impact isn't just the direct medical

00:18:29.319 --> 00:18:31.720
cost. It's about lost productivity, isn't it?

00:18:32.039 --> 00:18:35.519
Exactly that. When a younger adult develops debilitating

00:18:35.519 --> 00:18:38.220
pain and the limited mobility that can come with

00:18:38.220 --> 00:18:40.720
OA, it severely impacts their ability to work

00:18:40.720 --> 00:18:43.809
effectively. or sometimes to work at all. Leading

00:18:43.809 --> 00:18:45.970
to time off or even leaving work altogether?

00:18:46.170 --> 00:18:48.650
Yes, it significantly increases their risk of

00:18:48.650 --> 00:18:50.569
having to withdraw from the workforce early.

00:18:51.849 --> 00:18:54.069
The sources cite a really striking statistic.

00:18:54.170 --> 00:18:56.730
What's that? That arthritis... and OA is the

00:18:56.730 --> 00:18:59.670
most common form, increases a person's risk of

00:18:59.670 --> 00:19:02.630
being out of the labor force entirely by a staggering

00:19:02.630 --> 00:19:06.750
64%. 64%. That's a massive potential impact on

00:19:06.750 --> 00:19:08.549
someone's career path and financial stability.

00:19:08.650 --> 00:19:10.990
It's huge. And the sheer number of lost work

00:19:10.990 --> 00:19:13.869
days nationally, it's immense. How immense. The

00:19:13.869 --> 00:19:16.089
United States Bone and Joint Initiatives 2016

00:19:16.089 --> 00:19:18.690
report found that adults with osteoarthritis

00:19:18.690 --> 00:19:21.849
reported something like 180 .9 million total

00:19:21.849 --> 00:19:26.099
lost work days just between 2013 and 2014. And

00:19:26.099 --> 00:19:28.380
to put that to sharp relief, that figure represented

00:19:28.380 --> 00:19:31.640
34 % over a third of all lost work days reported

00:19:31.640 --> 00:19:33.539
for any medical condition during that period.

00:19:33.799 --> 00:19:36.599
A third of all lost work days across all conditions,

00:19:36.740 --> 00:19:40.019
just from OA. That statistic alone should make

00:19:40.019 --> 00:19:42.740
employers, policymakers, everyone really pay

00:19:42.740 --> 00:19:45.180
attention. It's a staggering figure. It highlights

00:19:45.180 --> 00:19:47.559
that OA is a leading cause of lost work time

00:19:47.559 --> 00:19:50.579
and productivity. Full stop. And the direct medical

00:19:50.579 --> 00:19:53.410
costs involved? Are they higher for younger patients,

00:19:53.609 --> 00:19:55.789
too? They were, according to the McLean and Adelol

00:19:55.789 --> 00:19:58.950
data cited in the sources. Even back in the early

00:19:58.950 --> 00:20:01.369
90s, they showed higher direct medical costs

00:20:01.369 --> 00:20:05.269
per year for patients under 65, around $2 ,800,

00:20:06.170 --> 00:20:08.509
than compared to those over 65 who are closer

00:20:08.509 --> 00:20:11.470
to $2 ,000 per year. Why would that be? Well,

00:20:11.470 --> 00:20:13.269
the reason this translates into what the source

00:20:13.269 --> 00:20:15.869
has called hefty cumulative costs over a lifetime

00:20:15.869 --> 00:20:18.069
is simply because these younger patients live

00:20:18.069 --> 00:20:20.670
with the disease for so much longer. Ah, right.

00:20:21.099 --> 00:20:23.200
years of needing treatment. Exactly. An older

00:20:23.200 --> 00:20:25.259
patient might develop OA and live with it for,

00:20:25.440 --> 00:20:28.059
say, 10 or 15 years. A younger patient diagnosed

00:20:28.059 --> 00:20:30.779
in their 30s or 40s could have it for 30, 40,

00:20:30.940 --> 00:20:33.839
even 50 years, accumulating medical expenses,

00:20:34.180 --> 00:20:36.099
needing potentially multiple interventions over

00:20:36.099 --> 00:20:38.400
that entire extended period. So for our listeners,

00:20:38.559 --> 00:20:40.440
many of whom are professionals navigating their

00:20:40.440 --> 00:20:42.799
own careers, this isn't just about potentially

00:20:42.799 --> 00:20:45.359
managing a future health issue for themselves

00:20:45.359 --> 00:20:47.759
maybe decades down the line. No, not at all.

00:20:47.920 --> 00:20:50.539
It's about understanding a force that significantly

00:20:50.319 --> 00:20:53.619
impacts workforce productivity right now, affects

00:20:53.619 --> 00:20:56.519
career longevity, and has major implications

00:20:56.519 --> 00:20:59.359
for long -term financial well -being, both for

00:20:59.359 --> 00:21:01.680
individuals and for the organizations they work

00:21:01.680 --> 00:21:05.599
for. That's a critical point to grasp. The economic

00:21:05.599 --> 00:21:09.000
burden of early OA and younger working -age individuals

00:21:09.000 --> 00:21:12.039
is a major concern that affects employers healthcare

00:21:12.039 --> 00:21:15.160
systems, and national economies, not just the

00:21:15.160 --> 00:21:17.579
person with the sore joint. Understanding this

00:21:17.579 --> 00:21:19.880
broader impact is vital for informed planning

00:21:19.880 --> 00:21:22.440
and resource allocation. OK, we've covered the

00:21:22.440 --> 00:21:24.839
subtle symptoms, the strong link to injury in

00:21:24.839 --> 00:21:27.579
younger people, and this huge economic cost.

00:21:28.099 --> 00:21:30.160
Now, let's really get into the science behind

00:21:30.160 --> 00:21:32.559
it. The sources fundamentally challenge that

00:21:32.559 --> 00:21:35.059
old idea of OA being just simple wear and tear,

00:21:35.200 --> 00:21:37.240
don't they? They position it much more as an

00:21:37.240 --> 00:21:40.400
inflammatory process. Yes. This shift in understanding

00:21:40.400 --> 00:21:42.240
has been a really big development, gathering

00:21:42.240 --> 00:21:45.380
pace since the 1990s, largely driven by advances

00:21:45.380 --> 00:21:48.640
in molecular biology. The old purely mechanical

00:21:48.640 --> 00:21:51.519
view is just too simplistic. So inflammation

00:21:51.519 --> 00:21:54.599
isn't just a side effect? No. The evidence presented

00:21:54.599 --> 00:21:57.079
here from multiple studies strongly points to

00:21:57.079 --> 00:21:59.940
inflammation within the joint, specifically inflammation

00:21:59.940 --> 00:22:02.880
of the synovial lining, synovitis, as a crucial

00:22:02.880 --> 00:22:05.880
feature of early OA pathology. It's not just

00:22:05.880 --> 00:22:07.880
something that happens late in the game. It seems

00:22:07.880 --> 00:22:09.960
to be part of the core disease process right

00:22:09.960 --> 00:22:12.259
from the beginning, especially after injury.

00:22:12.779 --> 00:22:14.960
How does this inflammatory process actually work

00:22:14.960 --> 00:22:17.380
then? How does it break down the joint? Well,

00:22:17.380 --> 00:22:19.759
it involves a pretty complex chain reaction.

00:22:20.519 --> 00:22:22.880
Damage or injury triggers the release of molecules

00:22:22.880 --> 00:22:25.319
within the joint that shouldn't normally be floating

00:22:25.319 --> 00:22:28.119
around freely. Bits of Damage Matrix, for example.

00:22:28.400 --> 00:22:30.759
Danger signals. Exactly. They act as danger signals,

00:22:30.859 --> 00:22:33.700
or what scientists call alarmans. These activate

00:22:33.700 --> 00:22:36.119
the innate immune system cells that reside within

00:22:36.119 --> 00:22:38.700
the joint tissues. This activation leads to a

00:22:38.700 --> 00:22:40.960
cascade involving the production of inflammatory

00:22:40.960 --> 00:22:44.000
mediators and destructive enzymes. Key players

00:22:44.000 --> 00:22:46.519
include enzymes that degrade the extracellular

00:22:46.519 --> 00:22:49.509
matrix. the stuff that holds cartilage together.

00:22:49.809 --> 00:22:52.970
Things like MMPs, matrix metalloproteinases,

00:22:53.509 --> 00:22:56.190
and NMMTS enzymes. They chew up the cartilage.

00:22:56.769 --> 00:22:58.829
Essentially, yes. They break down important components

00:22:58.829 --> 00:23:01.690
like agrikin and collagen. At the same time,

00:23:01.809 --> 00:23:04.289
the cartilage cells themselves, the chondroides,

00:23:04.670 --> 00:23:06.990
get switched into a catabolic state. Meaning?

00:23:07.069 --> 00:23:09.250
Meaning they start producing more of these breakdown

00:23:09.250 --> 00:23:11.650
enzymes and fewer of the molecules needed to

00:23:11.650 --> 00:23:14.279
maintain the tissue. They shift from building

00:23:14.279 --> 00:23:16.619
and maintaining to breaking down. This is driven

00:23:16.619 --> 00:23:19.299
by factors like inflammatory cytokines, signaling

00:23:19.299 --> 00:23:21.880
molecules like interleukin -1 and TNF -alpha,

00:23:22.140 --> 00:23:24.319
and prostaglandins, which are released in that

00:23:24.319 --> 00:23:26.259
inflammatory environment. And the source has

00:23:26.259 --> 00:23:29.200
mentioned specific molecular pathways being switched

00:23:29.200 --> 00:23:32.099
on, like NFKB. Yes. The activation of transcription

00:23:32.099 --> 00:23:34.740
factors like NFKB is seen as a central event

00:23:34.740 --> 00:23:37.539
in this process. When NFKB gets activated in

00:23:37.539 --> 00:23:39.660
cells within the cartilage, the bone, and the

00:23:39.660 --> 00:23:41.960
synovium, it essentially tells those cells to

00:23:41.960 --> 00:23:44.700
ramp up production of a whole host of inflammatory

00:23:44.700 --> 00:23:48.480
mediators, TNF alpha, IL -1 beta, IL -6, and

00:23:48.480 --> 00:23:50.920
others. Creating a hostile environment. Precisely.

00:23:51.039 --> 00:23:53.039
It creates this hostile inflammatory environment

00:23:53.039 --> 00:23:55.460
within the joint that accelerates tissue damage.

00:23:56.000 --> 00:23:58.200
It also leads to the excessive generation of

00:23:58.200 --> 00:24:01.640
reactive oxygen species, ROS. Free radicals.

00:24:01.720 --> 00:24:03.640
Think of them like damaging free radicals, yes.

00:24:04.180 --> 00:24:06.960
This causes oxidative stress, further tissue

00:24:06.960 --> 00:24:09.619
damage, and contributes to a kind of accelerated

00:24:09.619 --> 00:24:12.500
cellular aging or senescence within the joint

00:24:12.500 --> 00:24:15.019
tissues. It sounds like a vicious cycle. It really

00:24:15.019 --> 00:24:17.380
is often described as a feed -forward catabolic

00:24:17.380 --> 00:24:19.799
cycle. It involves all the joint tissues feeding

00:24:19.799 --> 00:24:22.259
into each other's dysfunction. And the evidence

00:24:22.259 --> 00:24:25.150
for this is overwhelming. You find elevated levels

00:24:25.150 --> 00:24:27.910
of these inflammatory markers in OA joint tissues

00:24:27.910 --> 00:24:30.869
and in the synovial fluid and synovitis that

00:24:30.869 --> 00:24:33.490
inflammation of the joint lining is consistently

00:24:33.490 --> 00:24:35.990
present even in the early stages of the disease.

00:24:36.309 --> 00:24:38.410
So it's a destructive cycle really powered by

00:24:38.410 --> 00:24:41.150
inflammation. Are there particular inflammatory

00:24:41.150 --> 00:24:43.829
signals or specific immune cells that seem especially

00:24:43.829 --> 00:24:47.190
important in early OA? Perhaps areas where intervention

00:24:47.190 --> 00:24:50.230
might be possible to break that cycle. Yes, interleukin

00:24:50.230 --> 00:24:52.829
-1 or IL -1 is definitely highlighted in the

00:24:52.829 --> 00:24:55.539
sources. They note that, particularly after an

00:24:55.539 --> 00:24:58.339
injury, there seem to be relatively unopposed

00:24:58.339 --> 00:25:01.019
increases in IL -1 activity within the joint.

00:25:01.519 --> 00:25:04.000
And IL -1 is bad for cartilage? It's strongly

00:25:04.000 --> 00:25:06.220
catabolic, yes. It drives cartilage breakdown.

00:25:06.759 --> 00:25:09.339
And levels of its natural inhibitor, IL -1 receptor

00:25:09.339 --> 00:25:13.200
antagonist, or IL -1RO, seem to decrease as cartilage

00:25:13.200 --> 00:25:15.789
damage gets worse. Laboratory studies also show

00:25:15.789 --> 00:25:17.509
that the superficial layers of cartilage are

00:25:17.509 --> 00:25:19.609
particularly vulnerable to damage induced by

00:25:19.609 --> 00:25:22.450
IL -1. Does this biochemical finding link back

00:25:22.450 --> 00:25:25.329
directly to how patients actually do, to the

00:25:25.329 --> 00:25:27.490
outcomes we talked about earlier? Yes. There's

00:25:27.490 --> 00:25:30.069
compelling evidence suggesting it does. The sources

00:25:30.069 --> 00:25:32.789
cite studies showing a direct correlation. Levels

00:25:32.789 --> 00:25:35.450
of inflammatory cytokines like IL -1 -alpha and

00:25:35.450 --> 00:25:38.450
cartilage degrading enzymes like MMP9 measured

00:25:38.450 --> 00:25:40.549
in the joint fluid on the very day someone has

00:25:40.549 --> 00:25:43.420
ACL reconstruction surgery. Right after the injury

00:25:43.420 --> 00:25:46.880
and surgery. Exactly. Those levels actually correlate

00:25:46.880 --> 00:25:49.880
with the amount of cartilage change seen on MRI

00:25:49.880 --> 00:25:52.779
scans three years later. Wow. And perhaps more

00:25:52.779 --> 00:25:55.420
importantly, higher levels of these inflammatory

00:25:55.420 --> 00:25:58.000
markers measured at the time of surgery were

00:25:58.000 --> 00:26:00.619
associated with worse patient -reported outcomes

00:26:00.619 --> 00:26:03.339
down the line. Things like lower quality of life

00:26:03.339 --> 00:26:06.569
scores, more pain, poorer function. That's powerful.

00:26:07.150 --> 00:26:09.470
It suggests the inflammatory environment present

00:26:09.470 --> 00:26:11.869
right from the start isn't just a temporary blip.

00:26:12.109 --> 00:26:14.529
It seems to set the stage for long -term problems.

00:26:14.650 --> 00:26:17.369
It really does. It indicates that this early

00:26:17.369 --> 00:26:19.930
heightened inflammation can lead to issues like

00:26:19.930 --> 00:26:22.369
recurrent joint swelling, persistent synovitis,

00:26:22.710 --> 00:26:24.730
and ultimately continued cartilage breakdown

00:26:24.730 --> 00:26:27.210
with long -term consequences. The sources also

00:26:27.210 --> 00:26:29.170
discuss the role of specific immune cells, don't

00:26:29.170 --> 00:26:32.170
they? Particularly T cells and macrophages. Yes,

00:26:32.170 --> 00:26:34.690
the chapter focusing on T cells makes point of

00:26:34.690 --> 00:26:37.430
stating its focus is on their role in early OA.

00:26:37.670 --> 00:26:39.950
Why? Because that's really the window of opportunity

00:26:39.950 --> 00:26:42.130
where we might actually be able to intervene

00:26:42.130 --> 00:26:46.250
effectively to prevent or truly modify the long

00:26:46.250 --> 00:26:48.809
-term disease course rather than just managing

00:26:48.809 --> 00:26:52.230
late -stage symptoms. Makes sense. How are T

00:26:52.230 --> 00:26:54.670
cells involved? Well, damaged joint cells release

00:26:54.670 --> 00:26:57.579
chemical signals. chemokines that act like beacons,

00:26:57.859 --> 00:26:59.759
attracting T cells from the bloodstream into

00:26:59.759 --> 00:27:02.700
the inflamed joint. Different types or subtypes

00:27:02.700 --> 00:27:05.240
of T cells seem to be involved. Different jobs.

00:27:05.460 --> 00:27:08.740
Broadly, yes. And the specific mix of cytokines

00:27:08.740 --> 00:27:11.279
already present in the joint environment influences

00:27:11.279 --> 00:27:13.559
which T cell types are recruited and what they

00:27:13.559 --> 00:27:16.430
subsequently do. Some might promote further inflammation,

00:27:16.650 --> 00:27:18.329
while others could potentially help to resolve

00:27:18.329 --> 00:27:19.930
it. Which subtexts are mentioned? The sources

00:27:19.930 --> 00:27:22.029
mention the general subtypes people might have

00:27:22.029 --> 00:27:26.089
heard of Th1, Th2, Th17, and TREGs and their

00:27:26.089 --> 00:27:28.769
broad functions. Th1 cells, for example, often

00:27:28.769 --> 00:27:31.009
associated with activating phagocytic cells,

00:27:31.650 --> 00:27:35.549
Th2 with responses to parasites, Th17 with bacterial

00:27:35.549 --> 00:27:38.690
defense, and TREGs are generally immunosuppressive.

00:27:38.890 --> 00:27:41.900
But it's complicated in no way. Very. The sources

00:27:41.900 --> 00:27:44.279
stress that the exact interplay between these

00:27:44.279 --> 00:27:46.779
different T -cell subsets within the OA -joint

00:27:46.779 --> 00:27:48.839
environment is still being unraveled and needs

00:27:48.839 --> 00:27:51.140
much more research, understanding that interplay

00:27:51.140 --> 00:27:54.220
is crucial if we want to develop targeted immunotherapies

00:27:54.220 --> 00:27:56.240
that could work early in the disease process.

00:27:56.500 --> 00:27:58.519
OK, so T -cells are players, but the details

00:27:58.519 --> 00:28:00.700
are still being worked out. What about macrophages?

00:28:01.059 --> 00:28:03.380
They're major immune cells too. Macrophages are

00:28:03.380 --> 00:28:06.039
definitely key players. They are known producers

00:28:06.039 --> 00:28:09.480
of inflammatory mediators like TNF -alpha. One

00:28:09.480 --> 00:28:11.440
animal model study mentioned showed that after

00:28:11.440 --> 00:28:13.880
an ACL injury, there were increased levels of

00:28:13.880 --> 00:28:15.900
a molecule called macrophage in inflammatory

00:28:15.900 --> 00:28:19.779
protein 1 gamma, in the joint lining, the synovium.

00:28:19.880 --> 00:28:22.680
MIP1 gamma. What does that do? Well, it acts

00:28:22.680 --> 00:28:25.000
as a potent chemoattractant, recruiting other

00:28:25.000 --> 00:28:27.480
inflammatory cells to the site. But interestingly,

00:28:27.579 --> 00:28:29.900
it also influences bone resorption by regulating

00:28:29.900 --> 00:28:32.420
osteoclasts, the cells that break down bone.

00:28:32.720 --> 00:28:35.039
Ah, so linking inflammation and bone changes?

00:28:35.240 --> 00:28:37.920
Potentially, yes. A study cited demonstrated

00:28:37.920 --> 00:28:40.660
that a specific type of T cell, the CD4 plus

00:28:40.660 --> 00:28:43.940
T helper cells, seemed to influence OA progression,

00:28:44.440 --> 00:28:47.500
partly by regulating this MIP1 production. How

00:28:47.500 --> 00:28:51.029
did they show that? In a mouse model, silencing

00:28:51.029 --> 00:28:55.009
the gene for MIP1 actually reduced the infiltration

00:28:55.009 --> 00:28:57.650
of immune cells and macrophages into the joint

00:28:57.650 --> 00:29:00.750
after injury. It also lowered inflammation markers

00:29:00.750 --> 00:29:03.529
like IL -1 expression, decreased the number of

00:29:03.529 --> 00:29:06.609
bone -resorbing osteoclasts, and ultimately reduced

00:29:06.609 --> 00:29:09.890
the amount of cartilage damage. Targeting MIP1

00:29:09.890 --> 00:29:12.210
could potentially interrupt both the inflammatory

00:29:12.210 --> 00:29:14.970
cascade and the associated bone changes. That

00:29:14.970 --> 00:29:17.630
sounds promising. It suggests it could be a potential

00:29:17.630 --> 00:29:20.200
therapeutic target, yes. Yeah. Though, obviously,

00:29:20.200 --> 00:29:22.200
translating that from mice to humans is a big

00:29:22.200 --> 00:29:24.920
step. Of course. It's clear the biology is incredibly

00:29:24.920 --> 00:29:28.000
complex and highly inflammatory. But can we really

00:29:28.000 --> 00:29:30.180
separate that entirely from mechanics? How does

00:29:30.180 --> 00:29:32.220
mechanical load, the forces going through the

00:29:32.220 --> 00:29:34.960
joint, fit into this inflammatory picture? This

00:29:34.960 --> 00:29:37.099
is a really critical intersection that the sources

00:29:37.099 --> 00:29:40.019
explore in detail. And it has huge implications

00:29:40.019 --> 00:29:42.500
for things like rehabilitation and advising people

00:29:42.500 --> 00:29:44.859
on activity levels. How so? Well, firstly, they

00:29:44.859 --> 00:29:46.880
cite studies showing that very high intensity,

00:29:47.220 --> 00:29:49.730
sudden impact loading like a jump landing, perhaps

00:29:49.730 --> 00:29:52.029
can actually cause chondrocyte death directly.

00:29:52.490 --> 00:29:55.490
Just kill the cartilage cells. Yes, through a

00:29:55.490 --> 00:29:58.829
specific cellular pathway involving the mitochondria,

00:29:59.190 --> 00:30:01.869
the cell's powerhouses, and the production of

00:30:01.869 --> 00:30:04.509
those reactive oxygen species, ROS we mentioned

00:30:04.509 --> 00:30:07.589
earlier. It suggests that sheer force can trigger

00:30:07.589 --> 00:30:10.269
a kind of biologically programmed cell death.

00:30:10.390 --> 00:30:13.170
It's not just physically squashing them. That's

00:30:13.170 --> 00:30:15.849
a direct biological link between excessive force

00:30:15.849 --> 00:30:18.970
and cell death. Is it preventable? Intriguingly,

00:30:19.109 --> 00:30:21.910
in laboratory settings, yes, disrupting this

00:30:21.910 --> 00:30:24.390
specific pathway, for example using a simple

00:30:24.390 --> 00:30:27.289
antioxidant compound, markedly decreased the

00:30:27.289 --> 00:30:29.789
ROS levels and the amount of cell death observed

00:30:29.789 --> 00:30:32.559
after impact loading. This points towards potential

00:30:32.559 --> 00:30:34.799
protective strategies, although applying that

00:30:34.799 --> 00:30:37.140
in vivo in a person is another matter. Still,

00:30:37.240 --> 00:30:39.519
fascinating. What else about mechanics? The sources

00:30:39.519 --> 00:30:41.920
also note that after an injury like an ACL tear,

00:30:42.339 --> 00:30:44.359
people often develop altered movement patterns.

00:30:44.660 --> 00:30:47.000
They might subconsciously avoid loading the injured

00:30:47.000 --> 00:30:50.279
leg, leading to underloading. Or they might compensate

00:30:50.279 --> 00:30:52.700
in ways that actually overload other parts of

00:30:52.700 --> 00:30:55.279
the same joint, or the other leg, during activities

00:30:55.279 --> 00:30:58.029
like walking, running, or squatting. And these

00:30:58.029 --> 00:31:00.890
abnormal loading patterns are strongly linked

00:31:00.890 --> 00:31:03.490
to subsequent degeneration in both the cartilage

00:31:03.490 --> 00:31:05.950
and the underlying bone. So altered mechanics

00:31:05.950 --> 00:31:09.250
drive degeneration? Yes. And furthermore, even

00:31:09.250 --> 00:31:12.789
in what we call idiopathic OA, the type not directly

00:31:12.789 --> 00:31:15.730
linked to a major injury altered mechanics resulting

00:31:15.730 --> 00:31:18.920
from previous Maybe minor injuries or alignment

00:31:18.920 --> 00:31:21.720
issues can accelerate the disease process. And

00:31:21.720 --> 00:31:23.660
this brings us back to that really crucial finding

00:31:23.660 --> 00:31:25.859
you mentioned earlier about the difference between

00:31:25.859 --> 00:31:29.339
high impact versus low impact loading and inflammation.

00:31:29.640 --> 00:31:31.700
Yes, this is foundational for thinking about

00:31:31.700 --> 00:31:34.339
activity. The research suggests that high impact

00:31:34.339 --> 00:31:36.259
loading seems to have the potential to actually

00:31:36.259 --> 00:31:38.960
increase pro -inflammatory activity within the

00:31:38.960 --> 00:31:42.059
joint, specifically by activating that NFKB pathway

00:31:42.059 --> 00:31:45.059
we discussed. So heavy impact can ramp up inflammation?

00:31:45.240 --> 00:31:48.079
It appears so. Conversely, lower intensity loading,

00:31:48.299 --> 00:31:50.859
more gentle, controlled movement appears to decrease

00:31:50.859 --> 00:31:52.839
this inflammatory activity. That's a critical

00:31:52.839 --> 00:31:55.359
distinction. It really is. This isn't just about

00:31:55.359 --> 00:31:57.859
avoiding physical damage to the tissue. It's

00:31:57.859 --> 00:32:00.700
about how mechanical forces directly influence

00:32:00.700 --> 00:32:03.140
the biological environment and the inflammatory

00:32:03.140 --> 00:32:06.430
signaling within the joint. This has profound

00:32:06.430 --> 00:32:08.470
implications for how we design rehabilitation

00:32:08.470 --> 00:32:11.170
programs after injury and how we advise patients

00:32:11.170 --> 00:32:14.349
on returning to activity. It strongly suggests

00:32:14.349 --> 00:32:17.109
that the quality and intensity of the load placed

00:32:17.109 --> 00:32:19.789
on the joint matter significantly for its long

00:32:19.789 --> 00:32:22.470
-term biological health, not just as mechanical

00:32:22.470 --> 00:32:25.650
integrity. That connection between specific mechanical

00:32:25.650 --> 00:32:28.049
loads and the underlying inflammatory pathways

00:32:29.029 --> 00:32:31.309
That feels like a major takeaway. It suggests

00:32:31.309 --> 00:32:33.630
rehab isn't just about restoring strength and

00:32:33.630 --> 00:32:36.349
movement. It's potentially about actively managing

00:32:36.349 --> 00:32:38.329
the biological environment through movement.

00:32:38.789 --> 00:32:40.509
Precisely. It opens up a whole new dimension

00:32:40.509 --> 00:32:42.829
to therapeutic exercise. Okay, let's shift gears

00:32:42.829 --> 00:32:45.690
now and talk about treatment strategies. Given

00:32:45.690 --> 00:32:48.269
this complex, evolving understanding of early

00:32:48.269 --> 00:32:50.529
OA, the inflammation, the mechanics, the injury

00:32:50.529 --> 00:32:52.910
link, what approaches are currently being used,

00:32:53.009 --> 00:32:55.210
or perhaps being explored for the future, the

00:32:55.210 --> 00:32:58.460
sources cover a pretty wide range. Starting logically

00:32:58.460 --> 00:33:01.480
with non -surgical options, which are often focused

00:33:01.480 --> 00:33:04.500
on managing symptoms initially. Pain management

00:33:04.500 --> 00:33:06.839
is obviously primary. What are the main options

00:33:06.839 --> 00:33:09.559
there? Well, simple analgesics like acetaminophen,

00:33:09.680 --> 00:33:12.660
paracetamol are noted as having a good safety

00:33:12.660 --> 00:33:15.099
profile, especially for older adults or those

00:33:15.099 --> 00:33:18.099
with stomach issues, but they lack a direct anti

00:33:18.099 --> 00:33:20.859
-inflammatory effect. Compared to NSAIDs? Compared

00:33:20.859 --> 00:33:23.599
to non -steroidal anti -inflammatory drugs, NSAIDs,

00:33:23.660 --> 00:33:26.599
yes. NSAIDs can reduce inflammation as well as

00:33:26.599 --> 00:33:29.440
pain. which might be advantageous, but they carry

00:33:29.440 --> 00:33:32.180
other risks, like gastrointestinal or cardiovascular

00:33:32.180 --> 00:33:34.619
side effects, particularly with long -term use.

00:33:34.880 --> 00:33:36.519
What about supplements do they get a mention?

00:33:36.779 --> 00:33:39.480
Oral vitamins, specifically vitamin C and D,

00:33:39.539 --> 00:33:42.259
are mentioned. This is partly based on NICE UK

00:33:42.259 --> 00:33:44.339
guidelines, which include them as an optional

00:33:44.339 --> 00:33:47.160
part of managing shoulder problems. But the sources

00:33:47.160 --> 00:33:49.220
discuss their potential relevance more broadly.

00:33:49.480 --> 00:33:51.460
How might they help? Vitamin C is highlighted

00:33:51.460 --> 00:33:54.000
for potential chondroprotective effects. It's

00:33:54.000 --> 00:33:56.750
an antioxidant, It might help reduce programmed

00:33:56.750 --> 00:33:59.670
cell death, apoptosis, in cartilage cells. And

00:33:59.670 --> 00:34:01.710
some studies suggest it can stimulate the production

00:34:01.710 --> 00:34:04.750
of key cartilage matrix components like agrikin

00:34:04.750 --> 00:34:07.730
and type 2 collagen. So potentially boosting

00:34:07.730 --> 00:34:10.610
the cartilage's own repair capacity? That's the

00:34:10.610 --> 00:34:13.949
theory. A study by Wang from 2004 is cited which

00:34:13.949 --> 00:34:16.449
linked higher vitamin C intake to a three -fold

00:34:16.449 --> 00:34:19.550
decrease in OA incidence and also pain reduction

00:34:19.550 --> 00:34:22.860
in people with hip or knee OA. The sources suggest

00:34:22.860 --> 00:34:25.239
these findings might be relevant even if direct

00:34:25.239 --> 00:34:27.179
evidence specifically for the shoulder, for instance,

00:34:27.559 --> 00:34:30.440
is less robust. Vitamin D is also important for

00:34:30.440 --> 00:34:32.480
bone health generally, which is relevant given

00:34:32.480 --> 00:34:35.099
the subconjural bone changes in OA. Okay. And

00:34:35.099 --> 00:34:36.960
rehabilitation. That must be central, especially

00:34:36.960 --> 00:34:39.440
after an injury or surgery. Absolutely vital.

00:34:39.840 --> 00:34:42.179
Using the example of post -shoulder surgery recovery,

00:34:42.719 --> 00:34:44.900
a structured progressive rehabilitation program

00:34:44.900 --> 00:34:47.119
is essential. What are the goals? Initially,

00:34:47.139 --> 00:34:49.619
to regain range of motion safely and prevent

00:34:49.619 --> 00:34:52.980
stiffness or scarring. Then, to progressively

00:34:52.980 --> 00:34:55.679
strengthen the key stabilizing muscles, like

00:34:55.679 --> 00:34:58.059
the rotator cuff and the muscles around the shoulder

00:34:58.059 --> 00:35:02.119
blade. And finally, a gradual controlled return

00:35:02.119 --> 00:35:05.500
to normal activities and potentially sport. Full

00:35:05.500 --> 00:35:07.460
recovery often takes a significant amount of

00:35:07.460 --> 00:35:09.920
time, maybe four to six months. or even longer.

00:35:10.139 --> 00:35:12.519
There's also that ongoing debate, particularly

00:35:12.519 --> 00:35:15.639
after injuries like ACL tears, about conservative

00:35:15.639 --> 00:35:18.420
management rehab alone versus surgical reconstruction.

00:35:19.119 --> 00:35:21.139
Do those sources touch on the cost effectiveness

00:35:21.139 --> 00:35:23.900
aspect of that? Yes, they do. Studies have tried

00:35:23.900 --> 00:35:25.960
to crunch the numbers on this. Some analyses,

00:35:26.179 --> 00:35:28.440
like one by Mather and colleagues cited, which

00:35:28.440 --> 00:35:31.199
use data from large cohort studies like Moon

00:35:31.199 --> 00:35:33.809
and Kana. Okay. They found that ACL reconstruction

00:35:33.809 --> 00:35:36.289
appeared to be more cost -effective than rehabilitation

00:35:36.289 --> 00:35:38.809
alone when measured in terms of gaining quality

00:35:38.809 --> 00:35:42.869
-adjusted life years, or QALYs. They even suggested

00:35:42.869 --> 00:35:44.869
it might offer overall cost savings in the long

00:35:44.869 --> 00:35:47.530
term. Another study by Lubowitz also supported

00:35:47.530 --> 00:35:49.510
the cost -effectiveness of reconstruction based

00:35:49.510 --> 00:35:53.119
on QAL gains. But it's not unanimous. Not entirely.

00:35:53.679 --> 00:35:56.059
A Swedish study mentioned found that while conservative

00:35:56.059 --> 00:35:59.440
management had lower initial costs, it also resulted

00:35:59.440 --> 00:36:03.639
in lower QALY gains, particularly when QALYs

00:36:03.639 --> 00:36:06.480
were calculated based on activity level achieved.

00:36:07.239 --> 00:36:09.679
So how you measure the outcome can influence

00:36:09.679 --> 00:36:12.460
the conclusion. They also mentioned specific

00:36:12.460 --> 00:36:15.159
cost -effectiveness analyses looking just at

00:36:15.159 --> 00:36:17.559
competitive athletes, where the demands are obviously

00:36:17.559 --> 00:36:19.769
higher. And this links right back to our earlier

00:36:19.769 --> 00:36:22.469
point about mechanical loading influencing inflammation,

00:36:22.570 --> 00:36:25.230
doesn't it? The sources emphasize that guidelines

00:36:25.230 --> 00:36:27.570
for returning to physical activity need to consider

00:36:27.570 --> 00:36:30.050
more than just strength or stability. Exactly.

00:36:30.289 --> 00:36:32.510
They need to consider how different activities

00:36:32.510 --> 00:36:35.010
and the specific loads they involve might be

00:36:35.010 --> 00:36:37.429
influencing that underlying inflammatory process

00:36:37.429 --> 00:36:39.289
and the health of the cartilage over the long

00:36:39.289 --> 00:36:41.769
term. It's not just about whether you can physically

00:36:41.769 --> 00:36:44.210
do an activity, but what impact that activity

00:36:44.210 --> 00:36:46.750
is having inside the joint at a biological level.

00:36:47.019 --> 00:36:49.760
High impact might feel okay initially, but could

00:36:49.760 --> 00:36:51.800
potentially be driving low -grade inflammation,

00:36:52.219 --> 00:36:53.880
whereas lower -intensity loading might actually

00:36:53.880 --> 00:36:56.340
be beneficial for joint homeostasis. A really

00:36:56.340 --> 00:36:58.440
important consideration for long -term joint

00:36:58.440 --> 00:37:01.920
health. Moving on to injection therapies. These

00:37:01.920 --> 00:37:04.599
are less invasive than surgery and seem to be

00:37:04.599 --> 00:37:07.400
very widely used for symptom control. Yes, they

00:37:07.400 --> 00:37:10.829
play a major role in OA management. Corticosteroid

00:37:10.829 --> 00:37:13.409
injection steroid jabs are very common for managing

00:37:13.409 --> 00:37:16.309
pain and symptom flare -ups. The sources note

00:37:16.309 --> 00:37:18.309
that using imaging guidance, like ultrasound,

00:37:18.889 --> 00:37:21.500
to ensure accurate placement improves the results.

00:37:21.719 --> 00:37:24.260
But there are downsides. Yes, a significant caveat

00:37:24.260 --> 00:37:27.480
is mentioned repeatedly. The potential for corticosteroids,

00:37:27.699 --> 00:37:29.840
especially with the repeated injections, to have

00:37:29.840 --> 00:37:32.159
harmful or deleterious effects on the cartilage

00:37:32.159 --> 00:37:35.239
itself. This is a particular concern in younger,

00:37:35.300 --> 00:37:37.420
more active patients where preserving cartilage

00:37:37.420 --> 00:37:40.500
health long term is paramount. Okay. What about

00:37:40.500 --> 00:37:43.420
hyaluronic acid injections, VSCO supplementation?

00:37:43.539 --> 00:37:46.840
Hyaluronic acid or HA, is a natural component

00:37:46.840 --> 00:37:49.400
of the synovial fluid in our joints. It provides

00:37:49.400 --> 00:37:51.780
lubrication, and shock absorption gives the fluid

00:37:51.780 --> 00:37:54.719
its viscosity. And that's reduced in OA. Yes.

00:37:54.739 --> 00:37:58.300
In OA, the concentration and the quality, the

00:37:58.300 --> 00:38:00.940
molecular weight, of HA in the joint fluid are

00:38:00.940 --> 00:38:04.420
reduced. So these injections aim to supplement

00:38:04.420 --> 00:38:07.340
that, to restore some of that lubrication, and

00:38:07.340 --> 00:38:09.760
potentially have some mild anti -inflammatory

00:38:09.760 --> 00:38:12.880
or pain -relieving effects. It's primarily seen

00:38:12.880 --> 00:38:15.179
as a symptomatic treatment, though. And platelet

00:38:15.179 --> 00:38:17.980
-rich plasma, PRP, that seems to be increasingly

00:38:17.980 --> 00:38:21.199
popular. PRP is another option. It involves taking

00:38:21.199 --> 00:38:23.440
a sample of the patient's own blood, spinning

00:38:23.440 --> 00:38:25.880
it down to concentrate the platelets, and then

00:38:25.880 --> 00:38:28.139
injecting that platelet -rich plasma back into

00:38:28.139 --> 00:38:30.760
the joint. What's the thinking behind that? Platelets

00:38:30.760 --> 00:38:32.840
are packed with growth factors and other signaling

00:38:32.840 --> 00:38:35.690
molecules. When injected into the joint, they

00:38:35.690 --> 00:38:38.210
release these factors, which are thought to influence

00:38:38.210 --> 00:38:41.010
the joint environment, potentially reducing inflammation,

00:38:41.489 --> 00:38:44.070
promoting some healing responses, improving symptoms

00:38:44.070 --> 00:38:46.530
and function. Does it work? The sources suggest

00:38:46.530 --> 00:38:50.030
PRP can have positive effects on joint homeostasis,

00:38:50.409 --> 00:38:53.489
reducing symptoms, improving function, and perhaps

00:38:53.489 --> 00:38:55.710
delaying the need for surgery in some patients.

00:38:56.550 --> 00:38:58.409
There's a note that it seems to work better in

00:38:58.409 --> 00:39:01.269
joints with earlier stages of degeneration rather

00:39:01.269 --> 00:39:04.820
than advanced OA. A meta -analysis is cited evaluating

00:39:04.820 --> 00:39:07.719
its effectiveness, particularly for knee cartilage

00:39:07.719 --> 00:39:10.659
problems and OA. Okay, so those are mainly managing

00:39:10.659 --> 00:39:13.000
symptoms, but there's huge interest now in approaches

00:39:13.000 --> 00:39:15.739
that might actually regenerate tissue or fundamentally

00:39:15.739 --> 00:39:19.429
change the disease process. biologics, like cell

00:39:19.429 --> 00:39:22.110
-based therapies. The sources delve quite deeply

00:39:22.110 --> 00:39:25.489
into mesenchymal stromal cells, or MSCs. Yes.

00:39:25.690 --> 00:39:28.010
MSCs, sometimes called mesenchymal stem cells,

00:39:28.389 --> 00:39:30.489
are a major focus of regenerative medicine research

00:39:30.489 --> 00:39:33.090
for OA. These are cells that can be isolated

00:39:33.090 --> 00:39:34.869
from various tissues in the body. Where do they

00:39:34.869 --> 00:39:37.389
come from? Lots of places. Bone marrow is a common

00:39:37.389 --> 00:39:40.550
source. Also adipose tissue, fat, the synovial

00:39:40.550 --> 00:39:42.869
membrane lining the joint itself, even umbilical

00:39:42.869 --> 00:39:45.550
cord tissue, dental pulp. The list is quite long.

00:39:45.670 --> 00:39:47.619
Are they all the same? And that's a critical

00:39:47.619 --> 00:39:50.539
point the sources make right away. MSCs derived

00:39:50.539 --> 00:39:52.159
from these different tissues are not equivalent.

00:39:52.679 --> 00:39:54.639
They have variations in their properties, their

00:39:54.639 --> 00:39:56.519
surface markers, their differentiation potential.

00:39:57.019 --> 00:40:00.139
This inherent variability makes comparing results

00:40:00.139 --> 00:40:02.380
from studies using MSCs from different sources

00:40:02.380 --> 00:40:05.960
quite complicated. Right. How are MSCs actually

00:40:05.960 --> 00:40:09.539
thought to help in an osteoarthritic joint? Well,

00:40:09.800 --> 00:40:11.780
there are potentially a couple of main mechanisms.

00:40:12.079 --> 00:40:14.539
One is their potential to differentiate, to turn

00:40:14.539 --> 00:40:17.780
into other cell types, like chondrocytes, cartilage

00:40:17.780 --> 00:40:22.099
cells, or osteoblasts, bone -forming cells. So

00:40:22.099 --> 00:40:24.039
theoretically, they could help rebuild damaged

00:40:24.039 --> 00:40:26.820
tissue directly. But is that the main way? Increasingly,

00:40:26.940 --> 00:40:29.320
the evidence points towards their paracrine effects

00:40:29.320 --> 00:40:31.780
being the dominant mechanism. Paracry. Meaning

00:40:31.780 --> 00:40:35.199
they work by signaling to other cells. MSCs release

00:40:35.199 --> 00:40:37.579
a whole cocktail of bioactive molecules, growth

00:40:37.579 --> 00:40:40.579
factors, cytokines, and importantly, extracellular

00:40:40.579 --> 00:40:42.780
vesicles, including exosomes. Exosomes. Tiny

00:40:42.780 --> 00:40:45.699
packages. Exactly. Tiny membrane -bound packages

00:40:45.699 --> 00:40:49.000
containing proteins, RNA, lipids. These secreted

00:40:49.000 --> 00:40:50.659
factors are thought to have powerful effects

00:40:50.659 --> 00:40:52.980
on the surrounding joint tissues, calming inflammation,

00:40:53.219 --> 00:40:55.739
immunomodulation, promoting tissue regeneration,

00:40:56.119 --> 00:40:59.639
reducing pain. analgesic effects. It's this communication

00:40:59.639 --> 00:41:01.719
with the existing joint cells that seems key.

00:41:02.079 --> 00:41:04.420
Have clinical trials actually shown that injecting

00:41:04.420 --> 00:41:07.599
MSCs can regenerate cartilage in OA patients?

00:41:08.079 --> 00:41:10.039
Clinical trials using intraarticular meaning

00:41:10.039 --> 00:41:12.360
injected into the joint MSCs are still relatively

00:41:12.360 --> 00:41:14.539
limited in number and scale. And the evidence

00:41:14.539 --> 00:41:17.440
for true robust articular cartilage regeneration

00:41:17.440 --> 00:41:20.360
that you can clearly see on an MRI scan has been

00:41:20.360 --> 00:41:22.460
variable. It's not consistently demonstrated

00:41:22.460 --> 00:41:25.119
yet. But any promising signs? Yes. One study

00:41:25.119 --> 00:41:27.139
specifically cited in the sources did report

00:41:27.139 --> 00:41:28.940
not only improved function and reduced pain,

00:41:29.239 --> 00:41:32.460
but also reduced cartilage defect size and, encouragingly,

00:41:32.699 --> 00:41:35.199
evidence of hyaline -like cartilage regeneration

00:41:35.199 --> 00:41:38.739
on MRI after injecting adipose -derived MSCs

00:41:38.739 --> 00:41:41.380
into osteoarthritic knees. So it is possible,

00:41:41.599 --> 00:41:43.860
but maybe not guaranteed. Are there ways to enhance

00:41:43.860 --> 00:41:46.929
their effect? The idea of combining MSCs with

00:41:46.929 --> 00:41:49.070
other things like supportive biomaterials or

00:41:49.070 --> 00:41:52.829
carriers, perhaps PRP, fibrin gel, or hyaluronic

00:41:52.829 --> 00:41:56.050
acid is being actively explored. The hope is

00:41:56.050 --> 00:41:58.630
that these might help the MSCs stay in the joint

00:41:58.630 --> 00:42:01.829
longer, survive better, and potentially promote

00:42:01.829 --> 00:42:04.309
their matrix -producing activity, enhancing the

00:42:04.309 --> 00:42:06.289
therapeutic benefit. What about practical things

00:42:06.289 --> 00:42:08.449
like how many cells to use or when to inject

00:42:08.449 --> 00:42:11.679
them? That's still largely unknown. Dose -response

00:42:11.679 --> 00:42:13.579
relationships have been observed in some studies

00:42:13.579 --> 00:42:16.039
suggesting more cells might be better up to a

00:42:16.039 --> 00:42:18.619
point by the optimal cell number, the best timing

00:42:18.619 --> 00:42:21.340
for injection, how soon after injury or at what

00:42:21.340 --> 00:42:23.900
stage of OA, and how often injections might be

00:42:23.900 --> 00:42:26.199
needed. These are all significant unanswered

00:42:26.199 --> 00:42:28.480
questions. But is there any consensus on timing?

00:42:28.760 --> 00:42:31.099
A key takeaway from the sources is that MSC therapy

00:42:31.099 --> 00:42:33.480
is likely to be most beneficial when applied

00:42:33.480 --> 00:42:36.260
as early as possible after a joint injury or

00:42:36.260 --> 00:42:38.800
in the early stages of OA development. Why early?

00:42:39.050 --> 00:42:41.909
The rationale is to intervene before extensive

00:42:41.909 --> 00:42:45.050
irreversible damage has occurred. The idea is

00:42:45.050 --> 00:42:48.550
to use the MSC's immunomodulatory and regenerative

00:42:48.550 --> 00:42:52.010
signaling effects to help restore joint homeostasis,

00:42:52.550 --> 00:42:54.730
calm that early inflammation, and protect the

00:42:54.730 --> 00:42:56.570
remaining cartilage from further degradation.

00:42:57.309 --> 00:42:59.289
Any evidence for that early intervention idea?

00:42:59.550 --> 00:43:02.070
A pre -clinical study in a large animal model

00:43:02.480 --> 00:43:04.500
relevant because their joints are more similar

00:43:04.500 --> 00:43:07.980
to humans, supported this. They injected specifically

00:43:07.980 --> 00:43:11.059
selected adipose -derived MSCs into the joint

00:43:11.059 --> 00:43:13.820
just four days after surgically inducing an injury.

00:43:13.940 --> 00:43:15.760
And the result? It prevented the progression

00:43:15.760 --> 00:43:18.699
of early post -traumatic OA changes, it reduced

00:43:18.699 --> 00:43:21.480
cartilage degeneration, and also lessened the

00:43:21.480 --> 00:43:24.019
abnormal subchondral bone changes that typically

00:43:24.019 --> 00:43:26.639
occur after such an injury. That's quite compelling

00:43:26.639 --> 00:43:28.900
evidence for the potential benefit of very early

00:43:28.900 --> 00:43:30.769
intervention. That preclinical finding really

00:43:30.769 --> 00:43:33.110
is compelling. What about bone marrow aspirate

00:43:33.110 --> 00:43:35.869
concentrate, BMAC? That's another cell -based

00:43:35.869 --> 00:43:38.090
approach using the patient's own tissue. Yes,

00:43:38.289 --> 00:43:40.989
BMAC is produced by taking bone marrow, usually

00:43:40.989 --> 00:43:43.130
from the hip bone, and then concentrating it.

00:43:43.210 --> 00:43:45.690
typically using a centrifuge. What's in it? It

00:43:45.690 --> 00:43:47.869
contains a mixed population of cells naturally

00:43:47.869 --> 00:43:50.550
present in bone marrow platelets, various types

00:43:50.550 --> 00:43:53.309
of immune cells, lymphocytes, monocytes, granulocytes,

00:43:53.469 --> 00:43:56.070
progenitor cells, and importantly a small proportion

00:43:56.070 --> 00:44:00.110
of MSCs and hematopoietic stem cells, HSCs. The

00:44:00.110 --> 00:44:01.989
concentration process typically increases the

00:44:01.989 --> 00:44:04.489
total number of nucleated cells several fold

00:44:04.489 --> 00:44:06.530
compared to the original bone marrow aspirate.

00:44:06.710 --> 00:44:09.639
And how is it being used for early OA? The Mbrede

00:44:09.639 --> 00:44:11.639
has shown some promise in studies for treating

00:44:11.639 --> 00:44:14.260
early OA and is generally considered safe as

00:44:14.260 --> 00:44:16.380
it's using the patient's own cells with minimal

00:44:16.380 --> 00:44:19.599
manipulation. Studies do report reductions in

00:44:19.599 --> 00:44:21.699
pain and improvements in joint function after

00:44:21.699 --> 00:44:24.920
BMAC injections. But are there limitations? Yes,

00:44:25.079 --> 00:44:26.860
the sources highlight some major limitations.

00:44:27.420 --> 00:44:30.119
Firstly, whether BMA truly leads to tissue regeneration

00:44:30.119 --> 00:44:33.099
is still unresolved. Secondly, the results reported

00:44:33.099 --> 00:44:35.539
in studies vary quite widely in terms of efficacy.

00:44:35.880 --> 00:44:38.539
Why the variability? It likely points to a real

00:44:38.539 --> 00:44:42.159
need for standardization in how the BMA is processed,

00:44:42.800 --> 00:44:45.460
which technique is used, and importantly, the

00:44:45.460 --> 00:44:47.739
final dosage or cell concentration injected.

00:44:48.079 --> 00:44:50.619
A big challenge is that many published clinical

00:44:50.619 --> 00:44:52.960
studies unfortunately don't report the specific

00:44:52.960 --> 00:44:55.539
cellular composition or concentration of the

00:44:55.539 --> 00:44:58.320
BMAC product they used. Making it hard to compare

00:44:58.320 --> 00:45:01.199
studies or know it actually works? Exactly. It

00:45:01.199 --> 00:45:03.119
makes it almost impossible to compare results

00:45:03.119 --> 00:45:05.599
properly or to figure out what might be a minimum

00:45:05.599 --> 00:45:08.900
effective dose or the optimal composition. And

00:45:08.900 --> 00:45:11.619
as with MSCs, longer -term follow -up studies

00:45:11.619 --> 00:45:13.760
are definitely needed to understand the exact

00:45:13.760 --> 00:45:16.159
effects of BMAs on disease progression over many

00:45:16.159 --> 00:45:19.010
years. So again, potential, but still a lot of

00:45:19.010 --> 00:45:21.730
unknowns, and a need for more rigorous, standardized

00:45:21.730 --> 00:45:24.610
research. What about using fat cells more directly,

00:45:24.829 --> 00:45:26.949
perhaps without expanding them in a lab first?

00:45:27.190 --> 00:45:29.650
The sources briefly touch on these less -processed,

00:45:29.769 --> 00:45:32.130
adipose -derived cell preparations. Things like

00:45:32.130 --> 00:45:34.750
stromal vascular fraction, or SVF, which is a

00:45:34.750 --> 00:45:38.269
mix of cells isolated from fat tissue, or microfragmented

00:45:38.269 --> 00:45:41.429
adipose tissue, sometimes called new fat or lipogems.

00:45:41.570 --> 00:45:43.769
Any evidence for these? Research, particularly

00:45:43.769 --> 00:45:46.380
some promising animal studies. for example, in

00:45:46.380 --> 00:45:50.159
dogs with OA, shows potential benefits. One study

00:45:50.159 --> 00:45:53.480
cited using microfragmented adipose tissue reported

00:45:53.480 --> 00:45:56.480
improvements in function, reduced pain, and fewer

00:45:56.480 --> 00:45:58.880
symptoms lasting for at least six months after

00:45:58.880 --> 00:46:01.360
injection. How are they thought to work? The

00:46:01.360 --> 00:46:03.579
suggested mechanism, again, seems to be primarily

00:46:03.579 --> 00:46:06.960
via paracrine effects, analgesic pain relieving,

00:46:07.360 --> 00:46:10.269
anti -inflammatory, and trophic. providing nourishing

00:46:10.269 --> 00:46:12.869
factors, activities from the cells within the

00:46:12.869 --> 00:46:15.690
fat tissue. The resulting repair tissue observed

00:46:15.690 --> 00:46:18.329
wasn't typically normal hyaline cartilage. again

00:46:18.329 --> 00:46:20.409
suggesting the action is mainly through signaling

00:46:20.409 --> 00:46:22.670
rather than the fat cells directly turning into

00:46:22.670 --> 00:46:24.929
cartilage. Okay. Another cutting -edge area mentioned

00:46:24.929 --> 00:46:28.050
is using just the signals themselves, MSC -derived

00:46:28.050 --> 00:46:31.130
extracellular vesicles or EVs. Yes, this is an

00:46:31.130 --> 00:46:34.610
exciting but very early stage field. EVs, particularly

00:46:34.610 --> 00:46:37.610
exosomes, are those tiny packages released by

00:46:37.610 --> 00:46:40.550
MSCs that carry many of the signaling molecules

00:46:40.550 --> 00:46:42.750
responsible for the therapeutic paracoin effects.

00:46:42.849 --> 00:46:44.489
So the idea is to deliver just the message, not

00:46:44.489 --> 00:46:47.960
the whole cell. Exactly. to harness the therapeutic

00:46:47.960 --> 00:46:50.599
potential without needing to inject living cells,

00:46:50.920 --> 00:46:52.900
which might overcome some challenges related

00:46:52.900 --> 00:46:55.760
to cell survival, sourcing, and consistency.

00:46:56.000 --> 00:46:58.900
But there are challenges with EVs, too. Significant

00:46:58.900 --> 00:47:02.059
challenges, yes. The sources point out that characterization

00:47:02.059 --> 00:47:04.880
is difficult. While there are some general pan

00:47:04.880 --> 00:47:08.599
-EV markers, like CD9 or CD63, there isn't a

00:47:08.599 --> 00:47:11.599
single unique marker to identify specific therapeutic

00:47:11.599 --> 00:47:14.980
EVs. And distinguishing potentially helpful EVs

00:47:14.980 --> 00:47:17.039
from other micro - vesicles or cellular debris

00:47:17.039 --> 00:47:19.739
is complex. And getting them to the right place.

00:47:20.340 --> 00:47:22.380
Biodistribution is another issue. Once injected

00:47:22.380 --> 00:47:24.079
into the joint, where do they go? How long do

00:47:24.079 --> 00:47:26.500
they stick around? Their fate is largely unknown,

00:47:26.500 --> 00:47:28.219
and there's potential for them to be cleared

00:47:28.219 --> 00:47:30.360
quite rapidly from the joint space, limiting

00:47:30.360 --> 00:47:33.699
their effect. So lots of potential, but many

00:47:33.699 --> 00:47:36.179
hurdles to overcome before EV therapy becomes

00:47:36.179 --> 00:47:38.480
a clinical reality. And looking even further

00:47:38.480 --> 00:47:41.780
ahead, perhaps, induced pluripotent stem cells,

00:47:41.900 --> 00:47:45.139
IPS cells. IPS cells represent another frontier.

00:47:45.739 --> 00:47:48.320
These are adult cells, like skin or blood cells,

00:47:48.780 --> 00:47:51.260
that have been reprogrammed in the lab back to

00:47:51.260 --> 00:47:54.639
a very early embryonic -like pluripotent state,

00:47:55.039 --> 00:47:56.960
meaning they can potentially develop into any

00:47:56.960 --> 00:47:59.460
cell type in the body. How might they be used

00:47:59.460 --> 00:48:02.059
for cartilage repair? The hope is that because

00:48:02.059 --> 00:48:04.440
they start from such an early stage, they could

00:48:04.440 --> 00:48:07.139
be directed to differentiate into chondrocytes

00:48:07.139 --> 00:48:09.699
that might integrate more effectively into the

00:48:09.699 --> 00:48:12.639
native cartilage defect, potentially mimicking

00:48:12.639 --> 00:48:15.039
normal cartilage development better than cells

00:48:15.039 --> 00:48:17.260
derived from more mature sources. Is this being

00:48:17.260 --> 00:48:19.510
tested? Research is still in the early phases.

00:48:20.090 --> 00:48:21.929
The source has mentioned studies exploring different

00:48:21.929 --> 00:48:24.630
protocols to guide iPS cells towards becoming

00:48:24.630 --> 00:48:27.070
cartilage cells using specific growth factors,

00:48:27.289 --> 00:48:29.610
co -culture systems, etc. There's debate about

00:48:29.610 --> 00:48:32.070
the best initial cell source for reprogramming

00:48:32.070 --> 00:48:34.489
peripheral blood or umbilical cord blood are

00:48:34.489 --> 00:48:36.530
mentioned as being easily accessible. What about

00:48:36.530 --> 00:48:39.590
safety? Is there a risk of tumors with pluripotent

00:48:39.590 --> 00:48:42.110
cells? That's always a key concern with pluripotent

00:48:42.110 --> 00:48:45.780
cells. However, the sources specifically note

00:48:45.780 --> 00:48:48.099
that the studies mentioned did not report any

00:48:48.099 --> 00:48:50.940
teratoma or tumor formation, which is obviously

00:48:50.940 --> 00:48:53.780
crucial for safety. But it's still a long way

00:48:53.780 --> 00:48:57.360
off clinical use. Very much so. The sources suggest

00:48:57.360 --> 00:48:59.860
that while certain lab protocols look promising

00:48:59.860 --> 00:49:02.940
pre -clinically, much more in vivo work in animal

00:49:02.940 --> 00:49:04.960
models and eventually rigorous clinical trials

00:49:04.960 --> 00:49:07.960
are needed before iPS cell -based therapies could

00:49:07.960 --> 00:49:10.380
even be considered for treating OA in patients.

00:49:10.650 --> 00:49:13.250
Okay, that's a fascinating overview of the non

00:49:13.250 --> 00:49:16.130
-surgical and biological approaches from established

00:49:16.130 --> 00:49:18.880
treatments to the very cutting edge. The sources

00:49:18.880 --> 00:49:22.260
also detail various surgical interventions, particularly

00:49:22.260 --> 00:49:25.219
relevant for focal cartilage defects, or perhaps

00:49:25.219 --> 00:49:27.360
more advanced issues, even in younger people

00:49:27.360 --> 00:49:30.079
sometimes. Let's start with cartilage restoration

00:49:30.079 --> 00:49:32.980
techniques for those localized defects. Microfracture

00:49:32.980 --> 00:49:35.159
is a common one. Yes, microfracture is a well

00:49:35.159 --> 00:49:37.219
-established technique. It involves creating

00:49:37.219 --> 00:49:39.360
small perforations, essentially drilling tiny

00:49:39.360 --> 00:49:41.719
holes through the base of the cartilage defect

00:49:41.719 --> 00:49:44.400
into the underlying subcontral bone. Why drill

00:49:44.400 --> 00:49:47.309
into the bone? The idea is to allow blood and

00:49:47.309 --> 00:49:49.329
bone marrow elements, including progenitor cells,

00:49:49.530 --> 00:49:52.469
potentially some MSCs, and growth factors to

00:49:52.469 --> 00:49:54.670
seep into the defect and stimulate a healing

00:49:54.670 --> 00:49:57.849
response. What kind of tissue forms? It typically

00:49:57.849 --> 00:50:00.150
results in the formation of fibrocartilage repair

00:50:00.150 --> 00:50:03.070
tissue. This isn't the same as the original hyaline

00:50:03.070 --> 00:50:05.750
cartilage. It's mechanically inferior, more like

00:50:05.750 --> 00:50:08.929
scar tissue, mainly composed of tight eye collagen

00:50:08.929 --> 00:50:12.110
instead of the normal type 2. But it does help

00:50:12.110 --> 00:50:14.670
to fill the defect. provides some covering for

00:50:14.670 --> 00:50:16.909
the bone, and the theory is it might protect

00:50:16.909 --> 00:50:19.230
the surrounding healthy cartilage from further

00:50:19.230 --> 00:50:22.010
damage or overload. Is it used for early OA?

00:50:22.309 --> 00:50:24.550
It's primarily established for treating smaller

00:50:24.550 --> 00:50:27.110
contained focal cartilage defects, particularly

00:50:27.110 --> 00:50:29.869
in younger active patients. It has been investigated

00:50:29.869 --> 00:50:32.550
for early OA, perhaps where there's a significant

00:50:32.550 --> 00:50:35.010
focal lesion driving symptoms, and reasonable

00:50:35.010 --> 00:50:37.400
midterm outcomes have been reported. What about

00:50:37.400 --> 00:50:39.639
techniques that aim for better quality repair

00:50:39.639 --> 00:50:42.420
tissue, more like the original hyaline cartilage?

00:50:42.659 --> 00:50:44.980
That's where techniques like autologous chondrocyte

00:50:44.980 --> 00:50:48.280
implantation, ACI, or its more modern matrix

00:50:48.280 --> 00:50:51.539
-assisted version, MACI, come in. This is usually

00:50:51.539 --> 00:50:54.940
a two -stage procedure. Two stages. Yes. In the

00:50:54.940 --> 00:50:58.019
first surgery, a small biopsy of healthy cartilage

00:50:58.019 --> 00:51:00.659
is taken from a less critical area of the patient's

00:51:00.659 --> 00:51:03.239
own knee. The chondrocytes from this biopsy are

00:51:03.239 --> 00:51:05.940
then isolated and grown, expanded in number,

00:51:06.380 --> 00:51:09.239
in a laboratory over several weeks. And the second

00:51:09.239 --> 00:51:11.840
stage? In the second surgery, these cultured

00:51:11.840 --> 00:51:14.039
chondrocytes are implanted back into the cartilage

00:51:14.039 --> 00:51:17.360
defect. In ACI, they're typically seated onto

00:51:17.360 --> 00:51:20.079
a biological scaffold or membrane, which is then

00:51:20.079 --> 00:51:22.460
secured into the defect, often covered with a

00:51:22.460 --> 00:51:24.860
patch. And this produces better cartilage. The

00:51:24.860 --> 00:51:26.960
goal, and often the result, is the formation

00:51:26.960 --> 00:51:29.780
of hyaline -like cartilage, which is biomechanically

00:51:29.780 --> 00:51:32.539
superior to the fibrocartilage from microfracture.

00:51:33.340 --> 00:51:35.719
Asimisi is generally used for larger defects,

00:51:35.960 --> 00:51:38.400
say over 2 to 4 square centimeters, and particularly

00:51:38.400 --> 00:51:40.480
in certain locations like the patellofemoral

00:51:40.480 --> 00:51:43.059
joint behind the kneecap. Long -term patient

00:51:43.059 --> 00:51:44.940
satisfaction rates are generally reported as

00:51:44.940 --> 00:51:46.980
being quite high. What are the downsides? Well,

00:51:47.079 --> 00:51:49.380
it's two surgeries, which means more recovery

00:51:49.380 --> 00:51:52.119
time and cost. And a major challenge highlighted

00:51:52.119 --> 00:51:55.119
in the sources is the very intensive and prolonged

00:51:55.119 --> 00:51:58.320
rehabilitation required afterwards. Getting quadriceps

00:51:58.320 --> 00:52:00.420
muscle strength back in particular can be a real

00:52:00.420 --> 00:52:03.420
struggle and can take up to a year or even longer.

00:52:03.579 --> 00:52:06.440
New rehab strategies like high -intensity training

00:52:06.440 --> 00:52:09.179
or blood flow restriction therapy are being explored

00:52:09.179 --> 00:52:11.260
to try and address this muscle weakness issue.

00:52:11.739 --> 00:52:14.920
Like microfracture, ACI is also being investigated

00:52:14.920 --> 00:52:17.980
for its potential role in treating specific situations

00:52:17.980 --> 00:52:21.400
in early OA. OK. What about using donor tissue

00:52:21.400 --> 00:52:24.400
instead, osteochondral allograft transplantation?

00:52:24.480 --> 00:52:27.280
Yes, an osteochondral allograft involves transplanting

00:52:27.280 --> 00:52:29.699
a cylinder or block of mature high -lying cartilage

00:52:29.699 --> 00:52:32.420
still attached to its underlying bone taken from

00:52:32.420 --> 00:52:34.460
a deceased donor. What are the advantages of

00:52:34.460 --> 00:52:36.940
using donor tissue? Several key advantages. Firstly,

00:52:37.099 --> 00:52:39.340
it's usually a single stage procedure, unlike

00:52:39.340 --> 00:52:43.179
ACI. Secondly, it immediately fills the defect

00:52:43.179 --> 00:52:47.300
with mature, structurally sound tissue. Thirdly,

00:52:47.539 --> 00:52:49.619
there's no need to harvest tissue from the patient's

00:52:49.619 --> 00:52:52.059
own healthy joint, avoiding donor site morbidity.

00:52:52.599 --> 00:52:54.840
It's also very versatile. It can be used for

00:52:54.840 --> 00:52:57.659
defects of almost any size, including very large

00:52:57.659 --> 00:52:59.820
or complex ones. And it's particularly useful

00:52:59.820 --> 00:53:02.940
for situations involving bone loss or abnormalities

00:53:02.940 --> 00:53:06.360
in the subchondral bone or complex shapes like

00:53:06.360 --> 00:53:08.860
on the patella. Any other benefits? A really

00:53:08.860 --> 00:53:10.880
interesting point made in the sources is that

00:53:10.880 --> 00:53:13.639
it's effectively a denervating technique. Because

00:53:13.639 --> 00:53:16.400
you're replacing the damaged, potentially painful

00:53:16.400 --> 00:53:19.300
subchondral bone along with the cartilage, patients

00:53:19.300 --> 00:53:21.599
often experience immediate pain relief from the

00:53:21.599 --> 00:53:23.980
procedure itself, which can be quite dramatic

00:53:23.980 --> 00:53:26.019
compared to techniques that rely on stimulating

00:53:26.019 --> 00:53:28.420
biological repair over time. That's significant.

00:53:28.659 --> 00:53:31.199
Is it used for early OA? It's being investigated

00:53:31.199 --> 00:53:33.699
for both early OA, especially with larger or

00:53:33.699 --> 00:53:36.579
deeper lesions, and for complex chondral problems

00:53:36.579 --> 00:53:38.420
that might not be suitable for other techniques.

00:53:39.050 --> 00:53:41.469
Research looking at the outcomes using refrigerated

00:53:41.469 --> 00:53:43.969
fresh allografts is mentioned. So a range of

00:53:43.969 --> 00:53:46.130
options for fixing localized cartilage damage,

00:53:46.489 --> 00:53:48.889
each with its own pros, cons, and indications.

00:53:49.570 --> 00:53:52.349
The sources also cover osteotomy procedures bone

00:53:52.349 --> 00:53:55.429
realignment surgery. Yes, high tibial osteotomy

00:53:55.429 --> 00:53:59.210
or HTO is specifically mentioned. This is a procedure

00:53:59.210 --> 00:54:01.349
typically used to correct bow -legged alignment

00:54:01.349 --> 00:54:04.050
or virus deformity in the knee. How does it help

00:54:04.050 --> 00:54:06.730
OA? By cutting and carefully realigning the upper

00:54:06.730 --> 00:54:09.610
part of the tibia, shin bone, it shifts the main

00:54:09.610 --> 00:54:11.670
weight -bearing axis of the leg away from the

00:54:11.670 --> 00:54:13.869
damaged intermedial compartment of the knee onto

00:54:13.869 --> 00:54:16.510
the healthier outer lateral compartment. This

00:54:16.510 --> 00:54:19.250
offloads the worn area, reducing pain and potentially

00:54:19.250 --> 00:54:22.070
slowing further degeneration. Is it done alongside

00:54:22.070 --> 00:54:25.639
cartilage repair? Often, yes. HDO can be combined

00:54:25.639 --> 00:54:28.579
with cartilage restoration procedures like microfracture,

00:54:28.840 --> 00:54:31.960
ACI, or allograft transplantation if there is

00:54:31.960 --> 00:54:34.360
a significant cartilage defect in the overloaded

00:54:34.360 --> 00:54:36.840
compartment. Studies looking at these combined

00:54:36.840 --> 00:54:39.159
procedures generally report reliable improvements

00:54:39.159 --> 00:54:42.360
in function over the medium to long term. One

00:54:42.360 --> 00:54:44.980
systematic review site had found favorable results,

00:54:45.480 --> 00:54:47.440
although conversion to a total knee replacement

00:54:47.440 --> 00:54:49.659
was still necessary in a small percentage of

00:54:49.659 --> 00:54:52.739
patients down the line, around 7 % at about six

00:54:52.739 --> 00:54:55.079
years follow -up in that review. So it can delay

00:54:55.079 --> 00:54:57.900
or avoid knee replacement for some? That's the

00:54:57.900 --> 00:55:00.119
goal, particularly in younger, more active patients

00:55:00.119 --> 00:55:03.250
with unicompartmental OA and malalignment. The

00:55:03.250 --> 00:55:05.190
sources correctly point out though that more

00:55:05.190 --> 00:55:07.510
studies with control groups are needed to really

00:55:07.510 --> 00:55:09.769
understand the added benefit of performing cartilage

00:55:09.769 --> 00:55:12.269
restoration at the same time as the osteotomy

00:55:12.269 --> 00:55:15.489
versus doing the osteotomy alone. They also briefly

00:55:15.489 --> 00:55:17.329
mentioned the potential for subchondral drilling

00:55:17.329 --> 00:55:20.170
or other techniques to possibly stimulate cartilage

00:55:20.170 --> 00:55:23.050
regeneration after the opposite type of osteotomy,

00:55:23.449 --> 00:55:25.789
valgus osteotomy for knock knees. Okay, let's

00:55:25.789 --> 00:55:28.170
switch joints now and move to the shoulder. The

00:55:28.170 --> 00:55:31.070
sources discuss shoulder arthroplasty shoulder

00:55:31.070 --> 00:55:34.130
replacement surgery. This seems more for advanced

00:55:34.130 --> 00:55:36.449
OA, but perhaps considered in younger patients

00:55:36.449 --> 00:55:38.710
too. Yes, the management pathway for shoulder

00:55:38.710 --> 00:55:41.329
arthritis mirrors the knee in many ways, starting

00:55:41.329 --> 00:55:43.949
with non -surgical options like physio, medication,

00:55:44.210 --> 00:55:46.710
injections. But surgery often becomes necessary

00:55:46.710 --> 00:55:49.730
for significant pain and loss of function. The

00:55:49.730 --> 00:55:52.730
source is specifically defined dislocation arthropathy

00:55:52.730 --> 00:55:55.610
as arthritis that develops as a consequence of

00:55:55.610 --> 00:55:58.550
previous shoulder instability, highlighting again

00:55:58.550 --> 00:56:01.409
how mechanical factors like recurrent dislocations

00:56:01.409 --> 00:56:04.190
can directly lead to cartilage breakdown and

00:56:04.190 --> 00:56:06.710
OA in the shoulder joint. For younger, more active

00:56:06.710 --> 00:56:10.070
patients needing surgery is total shoulder arthroplasty,

00:56:10.250 --> 00:56:12.449
TSA replacing both the ball and the socket, generally

00:56:12.449 --> 00:56:14.969
preferred for the best function. Often, yes.

00:56:15.409 --> 00:56:18.269
TSA is frequently the preferred option for primary

00:56:18.880 --> 00:56:21.559
Glenohumeral OA, arthritis of the main ball and

00:56:21.559 --> 00:56:24.219
socket joint, and active higher demand patients,

00:56:24.719 --> 00:56:26.639
provided their rotator cuff tendons are either

00:56:26.639 --> 00:56:29.320
intact or can be reliably repaired at the same

00:56:29.320 --> 00:56:32.760
time. When successful, TSA can offer significant

00:56:32.760 --> 00:56:35.039
improvements in both pain relief and range of

00:56:35.039 --> 00:56:37.739
emotion. But there are risks. A major risk highlighted

00:56:37.739 --> 00:56:40.440
is instability, especially if there are medium

00:56:40.440 --> 00:56:43.670
or large rotator cuff tears present. The sources

00:56:43.670 --> 00:56:45.829
state that about half of patients who have significant

00:56:45.829 --> 00:56:48.849
vocator cuff tears managed alongside a TSA end

00:56:48.849 --> 00:56:51.559
up needing revision surgery. There's also a trend

00:56:51.559 --> 00:56:54.000
mentioned towards performing TSA as an outpatient

00:56:54.000 --> 00:56:56.559
procedure in carefully selected younger patients,

00:56:57.000 --> 00:56:59.199
potentially saving costs. But patient selection

00:56:59.199 --> 00:57:02.239
based on age, BMI, other health conditions, and

00:57:02.239 --> 00:57:04.440
crucially, having good support at home is absolutely

00:57:04.440 --> 00:57:06.980
critical for safety and success. A big question

00:57:06.980 --> 00:57:09.559
for younger patients must be, how long do these

00:57:09.559 --> 00:57:12.139
shoulder replacements actually last, especially

00:57:12.139 --> 00:57:14.360
if they're active? That is indeed the challenge.

00:57:14.599 --> 00:57:17.380
While TSA generally offers the best functional

00:57:17.380 --> 00:57:20.440
outcomes, the potential for the implant components,

00:57:21.000 --> 00:57:23.559
particularly the plastic socket, glenoid, to

00:57:23.559 --> 00:57:26.280
wear out or loosen over time is a real consideration,

00:57:26.739 --> 00:57:29.019
and this risk is likely higher in more active

00:57:29.019 --> 00:57:31.079
individuals who place greater demands on the

00:57:31.079 --> 00:57:34.039
joint. One study cited found a survivorship rate

00:57:34.039 --> 00:57:37.239
of the implant of around 62 .5 % at 10 -year

00:57:37.239 --> 00:57:39.800
follow -up for patients under the age of 55.

00:57:40.380 --> 00:57:43.320
So nearly 40 % needed revision within 10 years

00:57:43.320 --> 00:57:45.659
in that group. In that particular study, yes.

00:57:46.179 --> 00:57:48.800
It indicates that while TSA can be very effective,

00:57:49.320 --> 00:57:51.380
the need for revision surgery within a decade

00:57:51.380 --> 00:57:54.380
or two is a distinct possibility for younger

00:57:54.380 --> 00:57:56.420
active patients, and that needs to be part of

00:57:56.420 --> 00:57:59.070
the conversation. And return to work or sport

00:57:59.070 --> 00:58:01.710
must be a huge factor for this demographic. Absolutely

00:58:01.710 --> 00:58:04.409
crucial. It's often a primary goal. The sources

00:58:04.409 --> 00:58:06.449
say the meta -analysis looking at return to play

00:58:06.449 --> 00:58:08.289
after different types of shoulder replacement.

00:58:08.389 --> 00:58:11.030
It showed higher rates after TSA. Over 90 % were

00:58:11.030 --> 00:58:12.750
able to return to some form of sport. That's

00:58:12.750 --> 00:58:15.789
high. Compared to reverse shoulder arthroplasty,

00:58:15.949 --> 00:58:18.980
RSA, or hemiarthroplasty, just replacing the

00:58:18.980 --> 00:58:22.239
ball, which were both around 70%. And importantly

00:58:22.239 --> 00:58:25.519
nearly 80 % of those returning after TSA were

00:58:25.519 --> 00:58:27.500
able to get back to the same level of play they

00:58:27.500 --> 00:58:29.780
enjoyed before their shoulder problems became

00:58:29.780 --> 00:58:32.750
severe. Any specific examples? High return rates

00:58:32.750 --> 00:58:35.230
to sports like golf after TSA are given as an

00:58:35.230 --> 00:58:39.030
example, often 90 -100%, with lower rates typically

00:58:39.030 --> 00:58:41.690
seen after RSA or hemiarthroplasty. However,

00:58:42.110 --> 00:58:44.309
a key point emphasized is that there are currently

00:58:44.309 --> 00:58:47.250
no clear evidence -based guidelines on exactly

00:58:47.250 --> 00:58:49.590
how long patients should wait before returning

00:58:49.590 --> 00:58:52.289
to demanding activities or sports. This needs

00:58:52.289 --> 00:58:54.789
to be highly individualized, based on their progress

00:58:54.789 --> 00:58:57.070
with regaining stability, strength, range of

00:58:57.070 --> 00:58:59.190
motion, and proprioception, their sense of joint

00:58:59.190 --> 00:59:01.570
position. The sources also get into some of the

00:59:01.570 --> 00:59:03.230
specific technical challenges surgeons face,

00:59:03.329 --> 00:59:05.150
like dealing with bone loss on the socket side,

00:59:05.230 --> 00:59:08.590
the glenoid. Yes. They discuss the Walsh classification

00:59:08.590 --> 00:59:11.369
system, which categorizes patterns of glenoid

00:59:11.369 --> 00:59:14.550
wear and bone loss in OA. They note that certain

00:59:14.550 --> 00:59:16.710
patterns, particularly those with significant

00:59:16.710 --> 00:59:18.789
bone erosion on the back of the socket, type

00:59:18.789 --> 00:59:21.110
E glenoids, are associated with higher rates

00:59:21.110 --> 00:59:23.889
of complications and the need for revision surgery

00:59:23.889 --> 00:59:27.469
after TSA. How do surgeons address that bone

00:59:27.469 --> 00:59:30.800
loss? Various strategies are used. For smaller

00:59:30.800 --> 00:59:33.719
defects, sometimes asymmetric reaming selectively

00:59:33.719 --> 00:59:36.480
shaping the remaining bone can work. For larger

00:59:36.480 --> 00:59:39.460
defects, bone grafting or using specialized augmented

00:59:39.460 --> 00:59:41.880
glenoid components with built -in wedges or steps

00:59:41.880 --> 00:59:44.119
might be necessary to restore the joint line

00:59:44.119 --> 00:59:47.130
and ensure stable fixation. However, the sources

00:59:47.130 --> 00:59:49.010
note that the results with some of these specialized

00:59:49.010 --> 00:59:51.670
augmented components are only moderate, with

00:59:51.670 --> 00:59:53.809
variable reports of loosening or revision rates.

00:59:54.289 --> 00:59:56.869
Okay. What about in reverse shoulder arthroplasty

00:59:56.869 --> 00:59:59.289
RSA? That's used more when the rotator cuff is

00:59:59.289 --> 01:00:01.570
badly damaged, right? Is stability a concern

01:00:01.570 --> 01:00:04.650
there, too? Yes. RSA is typically used when the

01:00:04.650 --> 01:00:06.949
rotator cuff is deficient and can't be repaired,

01:00:07.309 --> 01:00:09.849
as it relies more on the deltoid muscle for function.

01:00:10.730 --> 01:00:13.420
Stability is still critical. The sources discuss

01:00:13.420 --> 01:00:16.059
design features and surgical techniques aimed

01:00:16.059 --> 01:00:19.260
at enhancing stability in RSA, such as using

01:00:19.260 --> 01:00:21.500
an inferior eccentric glenosphere that's the

01:00:21.500 --> 01:00:23.980
ball component placed on the socket side in an

01:00:23.980 --> 01:00:26.980
RSA. Placing it slightly off -center and low

01:00:26.980 --> 01:00:29.780
helps prevent impingement or notching, where

01:00:29.780 --> 01:00:32.320
the arm bone implant rubs against the scapula,

01:00:32.460 --> 01:00:34.280
and it also improves stability by increasing

01:00:34.280 --> 01:00:37.320
the compressive forces across the joint. Placing

01:00:37.320 --> 01:00:39.539
the base plate component as low as possible on

01:00:39.539 --> 01:00:41.980
the glenoid is also recommended for stability.

01:00:42.300 --> 01:00:44.559
Any other techniques? Biomechanical studies cited

01:00:44.559 --> 01:00:46.880
suggest that tilting the glenoid component slightly

01:00:46.880 --> 01:00:50.159
downwards, about 15 degrees, also maximizes these

01:00:50.159 --> 01:00:52.659
compressive forces and reduces the risk of dislocation.

01:00:53.079 --> 01:00:54.960
They also touch on the role of the subscapularis

01:00:54.960 --> 01:00:57.760
muscle. The one at the front? Yes. The subscapularis

01:00:57.760 --> 01:01:00.500
is vital for preventing anterior dislocation

01:01:00.500 --> 01:01:04.030
after a standard TSA. Its role in RSA might be

01:01:04.030 --> 01:01:06.849
less critical, especially with certain lateralized

01:01:06.849 --> 01:01:09.469
RSA designs where the deltoid muscle provides

01:01:09.469 --> 01:01:12.130
more inherent compression, but it's still often

01:01:12.130 --> 01:01:14.769
repaired if possible. Speaking of the subscapularis,

01:01:15.010 --> 01:01:16.750
managing it during the surgical approach for

01:01:16.750 --> 01:01:19.369
a standard TSA seems really important for the

01:01:19.369 --> 01:01:21.650
outcome. It's absolutely critical for the stability

01:01:21.650 --> 01:01:23.969
and function of the final replacement. The sources

01:01:23.969 --> 01:01:25.809
discuss the different ways surgeons can handle

01:01:25.809 --> 01:01:28.309
the subscapularis tendon to get access to the

01:01:28.309 --> 01:01:30.690
joint. Sometimes it's cut transversely, tenotomy.

01:01:31.010 --> 01:01:34.090
Sometimes peeled off the bone, peel. Or sometimes

01:01:34.090 --> 01:01:35.809
a piece of the bone where it attaches is cut

01:01:35.809 --> 01:01:38.730
and later repaired. Lesser tuberosity, osteotomy,

01:01:38.949 --> 01:01:42.130
or LTO. Is one method better? Some biomechanical

01:01:42.130 --> 01:01:44.429
studies suggest the LTO might provide the best

01:01:44.429 --> 01:01:46.849
strength and stability after repair, although

01:01:46.849 --> 01:01:49.409
this isn't universally agreed upon. And healing

01:01:49.409 --> 01:01:52.989
can sometimes be an issue. What is crucial? regardless

01:01:52.989 --> 01:01:56.449
of the method used, is achieving a strong, reliable

01:01:56.449 --> 01:01:59.190
primary repair of the tendon or bone fragment

01:01:59.190 --> 01:02:02.829
at the end of the surgery. Failure of this subscapularis

01:02:02.829 --> 01:02:05.449
repair is a common reason for pain, weakness,

01:02:06.030 --> 01:02:08.289
instability, and potentially needing re -operation.

01:02:08.510 --> 01:02:10.989
Are there ways to avoid cutting it at all? The

01:02:10.989 --> 01:02:13.190
sources also mention a subscapularis sparing

01:02:13.190 --> 01:02:15.960
surgical approach. The idea here is to work around

01:02:15.960 --> 01:02:18.719
the main tendon, often by splitting fibers rather

01:02:18.719 --> 01:02:21.219
than detaching it completely. This potentially

01:02:21.219 --> 01:02:23.559
avoids the problems associated with repair failure

01:02:23.559 --> 01:02:26.679
and tendon degeneration and might allow for faster

01:02:26.679 --> 01:02:29.219
rehabilitation by preserving the upper, most

01:02:29.219 --> 01:02:30.699
functionally important portion of the muscle.

01:02:31.000 --> 01:02:33.360
Interesting. Beyond instability and managing

01:02:33.360 --> 01:02:35.699
the surgical approach, what are the other common

01:02:35.699 --> 01:02:37.679
complications discussed for shoulder replacement?

01:02:37.929 --> 01:02:40.369
A septic glenoid loosening, meaning the socket

01:02:40.369 --> 01:02:42.289
component coming loose without any infection

01:02:42.289 --> 01:02:45.070
being present, is highlighted as the most common

01:02:45.070 --> 01:02:47.429
reason for needing revision surgery after an

01:02:47.429 --> 01:02:50.590
anatomic TSA. Why does it loosen? It's often

01:02:50.590 --> 01:02:53.070
attributed to repetitive, uneven forces across

01:02:53.070 --> 01:02:55.710
the joint, causing micro -motion at the implant

01:02:55.710 --> 01:02:58.730
bone interface, leading to wear debris and eventually

01:02:58.730 --> 01:03:00.780
loosening. This is sometimes called the rocking

01:03:00.780 --> 01:03:03.800
horse phenomenon. Seeing radiolucent lines, or

01:03:03.800 --> 01:03:06.480
gaps, around cemented implants on x -rays can

01:03:06.480 --> 01:03:09.239
be an early sign, although using newer, more

01:03:09.239 --> 01:03:11.760
wear -resistant plastics like highly cross -linked

01:03:11.760 --> 01:03:15.400
polyethylene, XLPE, seems to reduce this risk.

01:03:15.820 --> 01:03:17.699
The debate between different socket fixation

01:03:17.699 --> 01:03:19.880
designs, keeled versus pegged, is mentioned,

01:03:20.260 --> 01:03:22.780
with large registry data suggesting similar revision

01:03:22.780 --> 01:03:25.599
rates nowadays, likely due to modern cementing

01:03:25.599 --> 01:03:28.369
techniques and better materials. Loosening is

01:03:28.369 --> 01:03:30.710
influenced by many factors. The patient's bone

01:03:30.710 --> 01:03:33.170
quality, the surgeon's accuracy in positioning

01:03:33.170 --> 01:03:35.929
the component, the implant design itself, and

01:03:35.929 --> 01:03:37.690
the forces the patient puts across the joint.

01:03:38.070 --> 01:03:40.030
Infection is always a risk with joint replacement

01:03:40.030 --> 01:03:42.769
too, right? Paraprosthetic joint infection, PJI.

01:03:43.030 --> 01:03:46.369
Yes. PJI is another serious complication, and

01:03:46.369 --> 01:03:48.869
it's critical to diagnose it accurately if a

01:03:48.869 --> 01:03:51.710
shoulder replacement isn't performing well. The

01:03:51.710 --> 01:03:54.269
sources refer to established diagnostic guidelines,

01:03:54.789 --> 01:03:57.250
like the International Consensus Meeting. ICM

01:03:57.250 --> 01:04:00.730
2018 criteria for shoulder PGI, which use a combination

01:04:00.730 --> 01:04:04.269
of major criteria like seeing pus or having multiple

01:04:04.269 --> 01:04:08.269
positive cultures and minor criteria like elevated

01:04:08.269 --> 01:04:10.510
inflammatory markers in blood or joint fluid

01:04:10.510 --> 01:04:12.809
to classify the likelihood of infection. How

01:04:12.809 --> 01:04:15.989
is it treated? Treatment is challenging. Antibiotics

01:04:15.989 --> 01:04:18.050
alone are usually insufficient because bacteria

01:04:18.050 --> 01:04:20.730
can form protective biofilms on the implant surface.

01:04:21.389 --> 01:04:23.170
Trying to keep the implant while just cleaning

01:04:23.170 --> 01:04:25.550
out the infection surgically, debridement and

01:04:25.550 --> 01:04:27.989
retention is debated with limited strong evidence

01:04:27.989 --> 01:04:30.070
supporting it routinely although it might be

01:04:30.070 --> 01:04:32.670
considered in very specific acute situations.

01:04:33.550 --> 01:04:35.630
Often more complex revision surgery involving

01:04:35.630 --> 01:04:37.809
implant removal is needed. Fractures around the

01:04:37.809 --> 01:04:40.820
implant are also mentioned. Yes. Paraprosthetic

01:04:40.820 --> 01:04:43.380
humerus fractures breaks in the upper arm bone

01:04:43.380 --> 01:04:46.340
around the stem of the implant or a known complication.

01:04:46.800 --> 01:04:48.860
Classifications exist to help surgeons decide

01:04:48.860 --> 01:04:51.619
on treatment. Fractures where the implant itself

01:04:51.619 --> 01:04:54.360
has become unstable typically require complex

01:04:54.360 --> 01:04:57.219
revision surgery to fix both the fracture and

01:04:57.219 --> 01:04:59.860
stabilize or replace the implant. Prevention

01:04:59.860 --> 01:05:02.639
is key here, emphasizing careful preoperative

01:05:02.639 --> 01:05:05.380
planning to choose the right implant size and

01:05:05.380 --> 01:05:08.019
meticulous surgical technique, especially during

01:05:08.019 --> 01:05:10.760
revision surgeries, to avoid weakening or damaging

01:05:10.760 --> 01:05:13.900
the bone. Even after a fracture heals surgically,

01:05:14.340 --> 01:05:16.780
patients often have some lasting functional limitations,

01:05:17.179 --> 01:05:19.420
particularly with range of motion. Finally, the

01:05:19.420 --> 01:05:21.599
source is briefly mentioned using arthroscopy

01:05:21.599 --> 01:05:23.900
keyhole surgery after a shoulder replacement

01:05:23.900 --> 01:05:26.000
has already been done. Is there a role for that?

01:05:26.219 --> 01:05:28.929
Potentially. Yes, in very selective circumstances.

01:05:29.210 --> 01:05:31.309
Arthroscopy might have a limited role in managing

01:05:31.309 --> 01:05:34.010
certain issues after arthroplasty, like persistent

01:05:34.010 --> 01:05:36.829
pain, stiffness, or limited movement that hasn't

01:05:36.829 --> 01:05:39.409
responded to rehabilitation, provided that infection

01:05:39.409 --> 01:05:41.429
and problems with the implant components themselves,

01:05:41.889 --> 01:05:44.389
like loosening or instability, have been confidently

01:05:44.389 --> 01:05:47.130
ruled out. What can be done arthroscopically?

01:05:47.489 --> 01:05:50.389
Procedures like releasing scar tissue, capsular

01:05:50.389 --> 01:05:54.039
release, Or removing adhesions, lysis of adhesions,

01:05:54.440 --> 01:05:56.920
can sometimes be performed using keyhole techniques.

01:05:57.739 --> 01:05:59.960
Studies looking at this are limited, but successful

01:05:59.960 --> 01:06:01.860
outcomes have been reported in carefully chosen

01:06:01.860 --> 01:06:04.000
patients where the underlying problem is soft

01:06:04.000 --> 01:06:06.960
tissue restriction rather than an implant issue.

01:06:07.639 --> 01:06:10.800
And one last thing on surgery. How is technology

01:06:10.800 --> 01:06:13.519
like computer navigation or patient -specific

01:06:13.519 --> 01:06:16.329
guides changing shoulder replacement? These technologies,

01:06:16.769 --> 01:06:19.210
things like preoperative planning software using

01:06:19.210 --> 01:06:21.909
CT scans, 3D printed patient -specific instrument

01:06:21.909 --> 01:06:24.730
guides, BSI, and real -time computer navigation

01:06:24.730 --> 01:06:26.929
systems used during surgery are definitely being

01:06:26.929 --> 01:06:29.269
adopted to try and improve the accuracy of place

01:06:29.269 --> 01:06:31.670
of the components, particularly the glenoid socket

01:06:31.670 --> 01:06:34.750
in both TSA and RSA. They help surgeons achieve

01:06:34.750 --> 01:06:36.869
the planned orientation and position more reliably.

01:06:37.070 --> 01:06:39.250
Does better accuracy mean better results for

01:06:39.250 --> 01:06:41.190
patients? Well, that's the crucial question.

01:06:41.789 --> 01:06:43.489
And the sources point out that there is currently

01:06:43.489 --> 01:06:46.510
little direct evidence to definitively prove

01:06:46.510 --> 01:06:49.690
that this increased surgical accuracy actually

01:06:49.690 --> 01:06:52.230
translates into improved long -term implant survival

01:06:52.230 --> 01:06:54.769
rates or better functional outcomes for patients.

01:06:55.329 --> 01:06:57.489
It makes intuitive sense that it should, but

01:06:57.489 --> 01:06:59.329
the high -level evidence isn't quite there yet.

01:06:59.789 --> 01:07:02.630
Interesting. Are there limitations to the current

01:07:02.630 --> 01:07:05.630
planning tech? They also note a limitation in

01:07:05.630 --> 01:07:08.269
most current planning software. It mainly focuses

01:07:08.269 --> 01:07:10.389
on the relationship between the ball and socket

01:07:10.389 --> 01:07:13.090
implants themselves. But the shoulder's actual

01:07:13.090 --> 01:07:15.869
functional motion is complex and heavily influenced

01:07:15.869 --> 01:07:17.570
by the movement of the shoulder blade on the

01:07:17.570 --> 01:07:20.550
rib cage, scapula thoracic motion, and other

01:07:20.550 --> 01:07:22.769
factors outside the joint, like posture or spinal

01:07:22.769 --> 01:07:25.570
curves. Ideally, future planning tools need to

01:07:25.570 --> 01:07:28.369
incorporate these broader factors for truly comprehensive,

01:07:28.809 --> 01:07:30.900
patient -specific surgical planning. That's been

01:07:30.900 --> 01:07:33.739
a really comprehensive deep dive into the whole

01:07:33.739 --> 01:07:36.699
landscape of early OA. We've gone from its subtle

01:07:36.699 --> 01:07:39.500
beginnings in complex biology right through to

01:07:39.500 --> 01:07:42.000
its significant personal and economic impact

01:07:42.000 --> 01:07:44.480
and the wide range of current and future treatment

01:07:44.480 --> 01:07:47.420
approaches. As we start to wrap up, let's just

01:07:47.420 --> 01:07:49.440
summarize some of the big challenges and perhaps

01:07:49.440 --> 01:07:51.699
the most promising areas for the future that

01:07:51.699 --> 01:07:53.900
emerged from these sources. Well, the challenges

01:07:53.900 --> 01:07:56.440
are certainly significant, aren't they? Diagnosing

01:07:56.440 --> 01:07:59.260
early OA reliably is still tough because it's

01:07:59.260 --> 01:08:03.340
often or symptoms are nonspecific. The underlying

01:08:03.340 --> 01:08:06.440
pathology is clearly a complex mix of inflammation,

01:08:07.059 --> 01:08:09.099
altered mechanics, and cellular dysfunction.

01:08:09.920 --> 01:08:11.940
Treatment outcomes are still quite variable,

01:08:12.260 --> 01:08:14.699
and there's a real urgent need for standardization,

01:08:14.760 --> 01:08:16.840
particularly for the newer biologic therapies

01:08:16.840 --> 01:08:19.899
like MSCs or BMAs, so we can actually compare

01:08:19.899 --> 01:08:22.420
results properly. And of course, surgical options,

01:08:22.479 --> 01:08:25.579
while powerful, come with inherent risks, limitations,

01:08:26.109 --> 01:08:28.189
and the particular challenge of achieving long

01:08:28.189 --> 01:08:30.529
-term durability in younger, more active patients.

01:08:30.789 --> 01:08:32.670
But despite all those challenges, the research

01:08:32.670 --> 01:08:35.189
definitely offers some promising directions forward,

01:08:35.369 --> 01:08:38.510
doesn't it? Absolutely. The potential of biologics,

01:08:38.750 --> 01:08:40.890
particularly MSCs and perhaps eventually their

01:08:40.890 --> 01:08:44.510
EVs, to truly modify the disease process rather

01:08:44.510 --> 01:08:47.149
than just treating symptoms is incredibly exciting,

01:08:47.310 --> 01:08:49.489
although much more rigorous research and well

01:08:49.489 --> 01:08:51.829
-controlled clinical translation are clearly

01:08:51.829 --> 01:08:54.930
needed. What else looks promising? Ongoing work

01:08:54.930 --> 01:08:57.689
that continues to clarify the specific inflammatory

01:08:57.689 --> 01:09:00.109
pathways involved and understanding the precise

01:09:00.109 --> 01:09:02.350
effects of different types and intensities of

01:09:02.350 --> 01:09:05.229
mechanical loading on joint tissues. These offer

01:09:05.229 --> 01:09:08.050
potential targets for new drug developments or,

01:09:08.050 --> 01:09:11.090
perhaps more immediately, more refined and biologically

01:09:11.090 --> 01:09:13.949
informed rehabilitation strategies. Improved

01:09:13.949 --> 01:09:15.829
surgical techniques, materials, and planning

01:09:15.829 --> 01:09:18.529
tools also continue to evolve, always aiming

01:09:18.529 --> 01:09:20.859
for better longevity and function. And although

01:09:20.859 --> 01:09:23.180
it's still in very early stages, the gene therapy

01:09:23.180 --> 01:09:25.619
research mentioned, aiming to perhaps deliver

01:09:25.619 --> 01:09:28.739
therapeutic molecules like IL -1 inhibitors directly

01:09:28.739 --> 01:09:30.880
and sustainably within the joint, represents

01:09:30.880 --> 01:09:33.239
another potential long -term avenue. So lots

01:09:33.239 --> 01:09:36.350
happening at the research level. Yes. But the

01:09:36.350 --> 01:09:38.970
crucial next step, as always, is translating

01:09:38.970 --> 01:09:41.430
all this promising basic science and preclinical

01:09:41.430 --> 01:09:44.229
work into practical, effective, and accessible

01:09:44.229 --> 01:09:47.069
treatments for patients. And that requires developing

01:09:47.069 --> 01:09:49.550
better tools to identify at -risk individuals

01:09:49.550 --> 01:09:52.670
early, refining our outcome measures, and running

01:09:52.670 --> 01:09:55.409
large, well -designed, long -term clinical trials.

01:09:55.970 --> 01:09:57.689
And finally, just bringing it back to you, the

01:09:57.689 --> 01:09:59.310
listener, navigating your professional life.

01:09:59.810 --> 01:10:03.210
How does understanding this really nuanced, detailed

01:10:03.210 --> 01:10:06.199
picture of early OA, science, the impact, the

01:10:06.199 --> 01:10:08.399
treatments, how does that tie back to your world?

01:10:08.779 --> 01:10:10.640
I think it's fundamental really. Understanding

01:10:10.640 --> 01:10:14.420
the why behind early OA, why injuries pose such

01:10:14.420 --> 01:10:16.260
a significant risk, why it's fundamentally an

01:10:16.260 --> 01:10:18.579
inflammatory process, understanding the true

01:10:18.579 --> 01:10:21.479
scale of the economic cost it equips you to make

01:10:21.479 --> 01:10:23.180
much more informed decisions, both personally

01:10:23.180 --> 01:10:25.340
and professionally. In what way? It's about recognizing

01:10:25.340 --> 01:10:28.020
potential personal risk. Perhaps if you or colleagues

01:10:28.020 --> 01:10:30.199
are very active or have sustained significant

01:10:30.199 --> 01:10:33.310
joint injuries in the past. It's about understanding

01:10:33.310 --> 01:10:35.869
the potential long -term implications for career

01:10:35.869 --> 01:10:39.010
longevity if OA develops early. It helps appreciate

01:10:39.010 --> 01:10:41.149
the critical need for effective early intervention

01:10:41.149 --> 01:10:43.510
and properly guided rehabilitation strategies,

01:10:43.890 --> 01:10:46.560
not just letting things slide. And it allows

01:10:46.560 --> 01:10:48.340
seeing the broader picture of how this condition

01:10:48.340 --> 01:10:50.279
impacts workforce productivity and health care

01:10:50.279 --> 01:10:54.060
resources. It reframes early OA not just as some

01:10:54.060 --> 01:10:55.939
distant health problem you might face in old

01:10:55.939 --> 01:10:58.819
age, but as a relevant professional and societal

01:10:58.819 --> 01:11:01.260
challenge that requires proactive awareness and

01:11:01.260 --> 01:11:03.479
engagement right now. That connection is powerful,

01:11:03.479 --> 01:11:05.640
thinking of it not just as a joint issue, but

01:11:05.640 --> 01:11:08.600
potentially a workforce issue. So to quickly

01:11:08.600 --> 01:11:11.060
recap just a few key insights from this deep

01:11:11.060 --> 01:11:13.920
dive, early OA is often a subtle, frequently

01:11:13.920 --> 01:11:15.880
injury -driven condition that's increasingly

01:11:15.880 --> 01:11:19.199
affecting younger, active individuals. Its underlying

01:11:19.199 --> 01:11:22.000
pathology is a complex interplay of inflammation

01:11:22.000 --> 01:11:24.699
and mechanics, challenging the old wear and pair

01:11:24.699 --> 01:11:27.600
notion. And it imposes a huge economic burden

01:11:27.600 --> 01:11:30.020
through lost productivity and health care costs.

01:11:31.430 --> 01:11:33.609
diagnosis and treatment remain challenging and

01:11:33.609 --> 01:11:36.449
are constantly evolving, promising new biological

01:11:36.449 --> 01:11:39.369
approaches like cell therapies alongside refined

01:11:39.369 --> 01:11:42.090
surgical techniques, offer hope for the future,

01:11:42.310 --> 01:11:44.409
but emphasize the critical need for continued

01:11:44.409 --> 01:11:47.449
research and standardization. A truly dynamic

01:11:47.449 --> 01:11:50.050
and challenging field indeed. So given the strong

01:11:50.050 --> 01:11:52.489
evidence we've discussed today, linking specific

01:11:52.489 --> 01:11:55.550
mechanical load profiles directly to those inflammatory

01:11:55.550 --> 01:11:58.369
pathways within the joint, here's perhaps a provocative

01:11:58.369 --> 01:12:01.430
thought to mull over. How can we fundamentally

01:12:01.430 --> 01:12:04.289
reinvent rehabilitation and training programs,

01:12:04.770 --> 01:12:07.050
not just to restore strength or function, but

01:12:07.050 --> 01:12:09.670
to actively manage and perhaps even interrupt

01:12:09.670 --> 01:12:12.550
the underlying biological progression of post

01:12:12.550 --> 01:12:14.810
-traumatic osteoarthritis in those high -demand

01:12:14.810 --> 01:12:16.689
individuals? That's a key question, isn't it?

01:12:16.890 --> 01:12:19.770
Moving rehab beyond mechanics into biology. It

01:12:19.770 --> 01:12:22.189
could have... potentially transformative implications.

01:12:22.750 --> 01:12:24.970
If you found this deep dive helpful and informative,

01:12:25.350 --> 01:12:27.289
please do take a moment to rate and share the

01:12:27.289 --> 01:12:29.229
show with your colleagues and professional network.

01:12:29.590 --> 01:12:31.689
It really helps us bring you more of the in -depth

01:12:31.689 --> 01:12:34.090
analysis you need to stay informed on critical

01:12:34.090 --> 01:12:34.930
topics like this.